Fertility and Sterility

Calendar: ASRM 2002 annual meeting abstracts
pp. i-xxxiii

Masthead - pu
pp. xxxiv-xxxiv(1)

Image-guided high intensity focused ultrasound: potential for minimally-invasive treatment of uterine fibroids
pp. 1-1(1)
Authors: Chan A.H.; Vaezy S.; Moore D.E.; Huynh G.; Paun M.; Fujimoto V.Y.

Development of an efficient method to obtain artificially produced haploid mammalian oocytes by transfer of G2/M phase somatic cells to GV ooplasts
pp. 1-1(1)
Authors: Nagy Z.P.; Chang C.-C.; Tian X.C.; Abdelmassih R.; Yang X.

Molecular diagnosis of ectopic pregnancy
pp. 1-2(2)
Authors: Barnhart K.T.; Kim C.; Hummel A.C.; Gerton G.L.

The endometrial biopsy as a diagnostic tool in the evaluation of the infertile patient. The Reproductive Medicine Network
pp. 2-2(1)

Wilms' tumor 1 inhibits aromatase P450 expression in human cells and is downregulated in endometriosis vs. endometrium-derived stromal cells
pp. 2-3(2)
Authors: Gurates B.; Sebastian S.; Yang S.; Tamura M.; Fang Z.J.; Bulun S.E.

Estradiol increases hippocampal syntaxin protein levels in ovariectomized primates
pp. 3-3(1)
Authors: Choi J.M.; Romeo R.D.; Brake W.G.; Bethea C.L.; Rosenwaks Z.; McEwen B.S.

Antral follicle count by transvaginal ultrasound is reflective of the actual primordial follicle pool
pp. 3-4(2)
Authors: Morris J.L.; Thyer A.C.; Soules M.R.; Klein N.A.

ASRM 2002 annual meeting abstracts
pp. 3-3(1)

Inhibition of EMP2 expression prevents mouse blastocyst attachment in vitro and implantation in vivo
pp. 4-4(1)
Authors: Dayal M.B.; Wadehra M.; Ord T.; Braun J.; Williams C.J.

Presence of hydrosalpinx correlated to endometrial inflammatory response in vivo
pp. 4-5(2)
Authors: Wells V.; Kalir T.; Mukherjee T.; Copperman A.B.

Do time from retrieval to transfer into IVF media and blood in follicular aspirates affect oocyte fertilization?
pp. 4-4(1)
Authors: Higdon H.L.; Crane M.M.; Blackhurst D.W.; Johnson J.E.; Boone W.R.

Committees: ASRM 2002 annual meeting abstracts
pp. 4-6(3)

Increased hyaluronan concentration in the embryo transfer medium results in a significant increase in human embryo implantation rate
pp. 5-5(1)
Authors: Schoolcraft W.; Lane M.; Stevens J.; Gardner D.K.

Assessment of the predictive value of follicular fluid cytokines and reactive oxygen species in IVF cycles
pp. 5-6(2)
Authors: Bedaiwy M.A.; Miller K.; Goldberg J.M.; Nelson D.R.; Agarwal A.; Falcone T.

Midluteal matrix metalloproteinase (MMP) and tissue inhibiting metalloproteinase (TIMP) levels after embryo transfer
pp. 6-6(1)
Authors: Abdallah M.A.; Nakajima S.T.; Eblen A.C.; Carrillo A.; Gercel-Taylor C.

Comparison of ICSI and conventional IVF on sibling oocytes in couples with or without mild male factor infertility
pp. 6-6(1)
Authors: Elizur S.; Levron J.; Seidman D.; Kiss S.; Baum M.; Dor J.

Baseline ultrasound and serum hormonal prediction of follicular response to gonadotropin stimulation during IVF
pp. 6-7(2)
Authors: Sylvestre C.V.; Child T.; Pirwany I.; Tan S.L.

Optimal treatment for poor responders to ovarian stimulation: Does IVF offer any advantages to IUI
pp. 7-7(1)
Authors: Wood S.J.; Sajjad Y.; Rahim R.; Searle T.; Lewis-Jones I.D.; Kingsland C.R.

Reducing the dose of hCG in high responders does not affect the outcomes of IVF
pp. 7-7(1)
Authors: Schmidt D.W.; Orris J.J.; Maier D.B.; Nulsen J.C.; Raboin D.; Benadiva C.A.

Defining the optimum number and frequency of embryo transfers in fellowship training
pp. 7-8(2)
Authors: Ginsburg E.S.; Jackson K.V.; Racowsky C.

Contents: ASRM 2002 annual meeting abstracts
pp. 7-7(1)

Ongoing development of a human blastocyst culture system
pp. 8-8(1)
Authors: Gardner D.K.; Lane M.; Stevens J.; Schoolcraft W.

Embryo developmental analysis can be used to decrease high order multiple pregnancies through reduction in the number of embryos selected for transfer
pp. 8-9(2)
Authors: Witmyer J.; Wang S.; LeGrow P.; Austin M.; Ferland K.; Powers R.D.

Developmental competence of blastocysts produced following intracytoplasmic sperm injection (ICSI)
pp. 9-9(1)
Authors: Rahil T.; Brody S.A.; Butler M.T.; Ho M.N.; Rousseau M.F.; Scull J.

Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation (GnRHa) and recombinant FSH stimulation
pp. 9-9(1)
Authors: Humaidan P.; Bungum L.; Bungum M.; Andersen C.Y.

Pregnancy outcome and complications in women age 40 or older undergoing in-vitro fertilization with autologous and donor oocytes
pp. 9-10(2)
Authors: Styne A.; Krey L.C.; Kwiatkowski A.; Licciardi F.; Noyes N.

A novel technique for immature oocyte retrieval
pp. 10-10(1)
Authors: Rutherford A.J.; Grondahl C.; Picton H.M.

IVM/F-ET in stimulated cycles for the prevention of ohss
pp. 10-10(1)
Authors: Lim K.-S.; Son W.-Y.; Yoon S.-H.; Lim J.-H.

Outpatient management of ovarian hyperstimulation syndrome (OHSS) without the use of albumin
pp. 10-11(2)
Authors: Esposito M.A.; Van Nest R.L.; Sagoskin A.W.; Stillman R.J.; Mottla G.L.

The use of hygroscopic cervical rods (Dilapan-S TM) in patients with cervical stenosis undergoing in vitro fertilization
pp. 11-11(1)
Authors: Serhal P.; Ranieri D.M.; Khadum I.; Wakim R.

Extensive screening of oocyte donors is nonetheless a worthwhile process
pp. 11-11(1)
Authors: Kump L.; Jansen V.; Baek K.; Lee S.; Schiffman M.; Licciardi F.

High rate of survival after cryopreservation of biopsied human embryos
pp. 11-12(2)
Authors: Stachecki J.J.; Willadsen S.M.; Cohen J.; Munne S.

A comparison of post-thaw survival and pregnancy rates in day 5 and day 6 frozen-thawed human blastocysts
pp. 12-12(1)
Authors: Clarke R.N.; Bodine R.; Zaninovic N.; Veeck L.L.

Clinical outcome after transfer of human blastocysts (BLs) vitrified on day 5 and on day 6 with a cryoloop technique
pp. 12-12(1)
Authors: Mukaida T.; Wada S.; Tomiyama T.; Oka C.; Takahashi K.; Kasai M.

The association of maximal endometrial thickness prior to progesterone supplementation with pregnancy outcome in frozen embryo transfers in endometria prepared by graduated estrogen therapy
pp. 12-13(2)
Authors: Check J.H.; Dietterich C.; Lurie D.; Check M.L.; Choe J.K.

Should we limit the age for ovarian tissue cryopreservation?
pp. 13-13(1)
Authors: Azem F.; Ben-Yosef D.; Kossoy N.; Cohen T.; Amit A.; Lessing J.

MAP kinase phosphorylation in relation to cytoskeletal behavior in mouse oocytes cultured in vitro after vitrification at the germinal vesicle stage
pp. 13-13(1)
Authors: Hwan L.S.; Eun P.S.; Jin J.H.; Ah K.H.; Man L.S.; Yul C.K.

Comparison of two freezing methods for human immature oocytes with cumulus or cumulus free: Slow freezing versus vitrification (including the effect of Taxol)
pp. 13-14(2)
Authors: Kyono K.; Haigo K.; Fukunaga N.; Nakajo Y.; Chiba S.; Fuchinoue K.

The survival and fertilization of human MII-stage oocytes cryopreserved by vitrification
pp. 14-14(1)
Authors: Yoon H.J.; Moon J.H.; Son W.-Y.; Lee S.-W.; Yoon S.-H.; Lim J.-H.

Oocyte donation using cryopreserved donor oocytes
pp. 14-15(2)
Authors: Yang D.; Winslow K.L.; Blohm P.L.; Brown S.E.; Nguyen K.; Brubaker C.

Oocytes or embryo storage?
pp. 15-15(1)
Authors: Porcu E.; Fabbri R.; Maria Ciotti P.; Frau F.; De Cesare R.; Venturoli S.

The use of outcomes-based data in reducing high order multiple pregnancies: The role of age, embryo score and ovum donation
pp. 15-15(1)
Authors: Peterson C.M.; Hatasaka H.H.; Campbell B.R.; Parker Jones K.; Adashi E.Y.; Carrell D.T.

Extended incubation of rhesus monkey cryopreserved sperm post thaw results in improved fertilization rates after ICSI
pp. 15-16(2)
Authors: Mitalipov S.M.; Yeoman R.R.; Kuo H.-C.; Thormahlen S.L.; Ramsey C.M.; Wolf D.P.

Chromosomal status of infertile couples, and the offspring created by ICSI
pp. 16-16(1)
Authors: Katagiri Y.; Neri Q.V.; Kent-First M.; Wang A.; Rosenwaks Z.; Palermo G.D.

Simple non-invasive screening of fathers and sons for Y chromosome deletions
pp. 16-16(1)
Authors: Katagiri Y.; Kent-First M.; Neri Q.V.; Rosenwaks Z.; Palermo G.D.

ICSI as a therapeutic measure for failed conventional in-vitro fertilization cycles: the cornell experience
pp. 17-17(1)
Authors: Hariprashad J.; Liotta D.; Cook C.; Zaninovic N.; Veeck L.

The endometrial function test (EFT) directs care and predicts ART outcome
pp. 17-17(1)
Authors: Kliman H.J.; McSweet J.C.; Grunert G.M.; Cardone V.R.S.; Cadesky K.; Keefe D.L.

Effect of embryo transfer catheter on implantation rates
pp. 17-18(2)
Authors: Mortimer S.T.; Fluker M.; Yuzpe A.

A multicenter prospective randomized controlled trial of in-vitro fertilization alone (IVF) versus combined in-vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) in unexplained infertility
pp. 18-18(1)
Authors: Foong S.C.; Greene C.A.; Tan S.L.; Tough S.C.

Sharing oocyte donors makes more sense scientifically, clinically, and financially
pp. 18-19(2)
Authors: Licciardi F.; Kump L.; Berkeley A.; Noyes N.; Grifo J.; Krey L.

Cost effectiveness modeling comparing recombinant FSH with urinary FSH for ovarian stimulation: a multinational evaluation
pp. 18-18(1)
Authors: Auray J.-P.; Duru G.; Daya S.; Beresniak A.

Daily low dose recombinant hCG and recombinant FSH: a novel stimulation protocol for IVF
pp. 19-19(1)
Authors: Martin L.; Del Marek; Doody K.; Nackley A.; Doody K.

A randomized, prospective study of microdose leuprolide vs. ganirelix in IVF cycles for poor response patients
pp. 19-20(2)
Authors: Schmidt D.W.; Bremner T.; Orris J.J.; Maier D.B.; Benadiva C.A.; Nulsen J.C.

Individual treatment using the GnRH antagonist Cetrotide(R): optimization of treament
pp. 20-20(1)
Authors: Ludwig M.; Katalinic A.; Banz C.; Diedrich K.

Is rapid follicular development during controlled ovarian hyperstimulation (COH) for IVF and ICSI detrimental to success rate?
pp. 20-20(1)
Authors: Ghobara T.; Vandekerckhove P.; Kennedy R.

Intercycle variability in antral follicle count and its effect upon stimulation quality in in vitro fertilization
pp. 20-21(2)
Authors: Hansen K.R.; Morris J.L.; Soules M.R.

Maternal balanced translocation is a risk factor for poor response to ovarian stimulation
pp. 21-21(1)
Authors: Chen S.H.; Escudero T.; Cekleniak N.A.; Sable D.B.; Garrisi M.G.; Munne S.

Premature luteinization during GnRH antagonists cycles in IVF adversely affects pregnancy and implantation rates
pp. 21-22(2)
Authors: Valencia I.; Bosch E.; Troncoso C.; Simon C.; Remohi J.; Pellicer A.

Elevated FSH&unknown;LH ratio in the presence of normal hormonal values predicts poor ovarian response in controlled ovarian hyperstimulation
pp. 22-22(1)
Authors: Shrim A.; Weizs B.; Kiss S.; Dor J.

Is exogenous LH necessary when using GnRH antagonist in IVF ovarian hyperstimulation?
pp. 22-22(1)
Authors: Noyes N.; Chung K.; Katz J.; Krey L.

Plateau or drop in estradiol (E2) on the day after initiation of the GnRH antagonist antagon&unknown; in in-vitro fertilization (IVF) treatment cycles does not affect pregnancy outcome
pp. 22-23(2)
Authors: Shapiro D.; Carter M.; Mitchell-Leef D.; Wininger D.

Chronic low-dose antiprogestin impairs preimplantation embryogenesis, but not oocyte nuclear maturation or fertilization in rhesus monkeys
pp. 23-23(1)
Authors: Borman S.M.; Chwalisz K.; Stouffer R.L.; Zelinski-Wooten M.B.

In vivo contraceptive activity of novel dual-function microbicides: aryl phosphate derivatives of bromo-methoxy zidovudine (compounds WHI-05 and WHI-07)
pp. 23-23(1)
Authors: D'Cruz O.J.; Uckun F.M.

Two-year toxicity and carcinogenicity study of the aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07), a novel dual-function microbicide
pp. 23-24(2)
Authors: D'Cruz O.J.; Erbeck D.; Waurzyniak B.; Uckun F.M.

Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during and after both simulated and real intercourse
pp. 24-24(1)
Authors: Pretorius E.S.; Barnhart K.T.; Timbers K.; Malamud D.

A pharmacokinetic interaction study of NuvaRing(R) and a vaginally administered spermicide or antimycotic
pp. 24-25(2)
Authors: Alexander N.J.; Haring T.; Mulders T.

Acceptability of NuvaRing(R), a new method of combined contraception
pp. 25-25(1)
Authors: Waldbaum A.S.; Funk S.; Alexander N.J.

An open-label noncomparative study to evaluate the vagina and cervix of NuvaRing(R) users
pp. 25-25(1)
Authors: Archer D.; Raine T.; Darney P.; Alexander N.J.

Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low dose oral contraceptive: a randomized trial
pp. 25-25(1)
Authors: Kwiecien M.; Edelman A.; Nichols M.D.; Jensen J.T.

A prospective, randomized, placebo-controlled trial of mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate (DMPA)
pp. 25-26(2)
Authors: Nicosia A.F.; Dutton C.; Lu J.; Felix J.C.; Paulson R.J.; Jain J.K.

Angiogenic and proliferative effects of Norplant on endometrial histology
pp. 26-26(1)
Authors: Pritts E.A.; Ryan I.; Mueller M.D.; Zaloudek C.J.; Darney P.D.; Taylor R.N.

Multimedia support for couples in infertility treatment
pp. 26-27(2)
Authors: Cousineau T.M.; Lord S.E.; Corsini E.; Seibring A.R.

Deciding about IVF: what's important to infertile couples?
pp. 27-27(1)
Authors: Millstein S.G.; Katz P.; Pasch L.

Disclosure patterns in couples who have conceived via oocyte donation
pp. 27-27(1)
Authors: Greenfeld D.A.; Klock S.C.; Rausch D.T.

Ethnic differences in presentation for infertility patients
pp. 27-28(2)
Authors: Bevilacqua K.; Chervenak J.; Witt B.

The social impact of infertility
pp. 28-28(1)
Authors: Katz P.; Millstein S.; Pasch L.

Children conceived through ICSI and IVF at 5 years of age: behavioral adjustment, parenting stress and attitudes: a comparative study
pp. 28-29(2)
Authors: Gibson F.L.; McMahon C.A.; Cohen J.; Leslie G.I.; Saunders D.M.

Anonymous oocyte donation: a follow-up analysis of donors' experiences
pp. 29-29(1)
Authors: Jordan C.; Belar C.D.; Williams R.S.

Post donation psychological status of anonymous oocyte donors
pp. 29-29(1)
Authors: Klock S.C.; Stout J.E.; Davidson M.

Views and practices about record keeping and dissemination in donor conception
pp. 29-30(2)
Authors: Braverman A.M.; Benward J.M.; Scheib J.E.

Preimplantation genetic diagnosis (PGD) in latino american population: patient's opinion
pp. 30-30(1)
Authors: Fernandez D.O.; Olmedo S.B.; Chillik C.; Sabrina De Vincentiis

Clinical characterization of 42 oligospermic or azoospermic men with microdeletion of the AZFc region of the y chromosome, and of 18 children conceived via intracytoplasmic sperm injection
pp. 30-30(1)
Authors: Oates R.D.; Silber S.; Brown L.; Page D.

Bilateral molecular defects in infertile men with left varicocele
pp. 31-31(1)
Authors: Benoff S.H.; Dubrovsky L.; Millan C.; Hurley I.R.; Marmar J.

Alarming tumor rate and high sperm recovery rate in cases of secondary azoospermia
pp. 31-31(1)
Authors: Kessler B.D.; Honig S.C.

Gene expression analysis by microarrays: are genetic ''signatures'' better for classifying infertile testis biopsies?
pp. 31-32(2)
Authors: Fox M.; Ares X.; Turek P.J.; Haqq C.; Pera R.A.R.

Sperm motility in men with spinal cord injury (SCI) is enhanced by inactivating cytokines in the seminal plasma
pp. 32-32(1)
Authors: Randall J.M.; Basu S.; Aballa T.C.; Lynne C.M.; Brackett N.L.

Increased incidence of triplet repeat diseases expanded alleles in azoospermic men: a new concern for ICSI?
pp. 32-32(1)
Authors: Maduro M.R.; Casella R.; Smith A.G.; Lamb D.J.

Detection of a novel mutation in the testis-specific antizyme-3 gene
pp. 32-33(2)
Authors: Christensen G.; Ivanov I.; Atkins J.; Schlegel P.; Mielnik A.; Carrell D.

Male infertility on the internet
pp. 33-33(1)
Authors: Zahalsky M.P.; Lam S.K.; Diblasio C.; Nagler H.M.

Serum mullerian-inhibiting substance is a reliable predictor of the ovarian follicular status
pp. 33-34(2)
Authors: Fanchin R.; Taieb J.; Schonauer L.M.; Hosny G.; Torrisi C.; Frydman R.

Premature follicle luteinization as a paracrine regulator of androstenedione (A4) in prenatally androgenized (PA) female rhesus monkeys receiving follicle-stimulating hormone (FSH) therapy for in vitro fertilization (IVF)
pp. 34-34(1)
Authors: Dumesic D.A.; Schramm R.D.; Peterson E.; Paprocki A.M.; Zhou R.; Abbott D.H.

A randomized study comparing doses of metformin in obese women with polycystic ovary syndrome (PCOS)
pp. 34-34(1)
Authors: Harborne L.R.; Fleming R.

The polycystic ovary is full of sound and fury but signifies nothing
pp. 34-35(2)
Authors: Legro R.S.; Chiu P.; Kunselman A.; Demers L.M.; Dodson W.C.; Dunaif A.

Characterizing ectopic pregnancies that rupture with methotrexate therapy
pp. 35-35(1)
Authors: Heard M.J.; Dudley P.; Sangi-Haghpeykar H.; Carson S.A.; Buster J.E.

Long-term survival of human spermatogonial stem cells in mouse testes
pp. 35-36(2)
Authors: Patrizio P.; Nagano M.; Brinster R.L.

Rosiglitazone in insulin-resistant women with polycystic ovary syndrome (PCOS): effects on ovarian function and metabolism
pp. 36-36(1)
Authors: Cataldo N.A.; Abbasi F.; McLaughlin T.L.; Fechner P.Y.; Reaven G.M.; Giudice L.C.

Semaphorin E and its receptors neuropilin 1 & 2 in human endometrium
pp. 36-36(1)
Authors: Germeyer A.; Tulac S.; Nayak N.R.; Giudice L.C.; Kao L.C.

Molecular mechanisms by which diethylstilbestrol (DES) alters hoxa10 gene expression
pp. 36-37(2)
Authors: Akbas G.E.; Selam F.B.; Song J.; Taylor H.S.

Application of DNA microarray technology to study genes controlled by progesterone in human endometrial stromal cells in vitro
pp. 37-37(1)
Authors: Okada H.; Oku H.; Nakaoka Y.; Fukuda A.; Morimoto Y.; Kanzaki H.

Optimizing an ovarian tissue cryopreservation regimen: evaluation of the effect of temperature and exposure time to propanediol (PPD) on follicular viability
pp. 37-38(2)
Authors: Posada M.N.; Garcia J.E.; Kolp L.A.

Novel associations between specific sperm morphological defects and increased seminal reactive oxygen species (ROS)
pp. 38-38(1)
Authors: Saleh R.A.; Aziz N.; Lewis-Jones I.; Sharma R.K.; Thomas A.J.; Agarwal A.

Assessment of differential contribution of spermatozoa and leukocytes to reactive oxygen species production in semen using nitroblue tetrazolium (NBT) reduction test
pp. 38-39(2)
Authors: Esfandiari N.; Saleh R.A.; Sharma R.K.; Nelson D.R.; Thomas A.J.; Agarwal A.

Double-edged role of nitric oxide in pre-implantation embryo apoptosis
pp. 39-39(1)
Authors: Esfandiari N.; Falcone T.; Agarwal A.; Attaran M.; Nelson D.R.; Sharma R.K.

A retrospective analysis: seasonal decline in implantation rates (IR) and its correlation with increased levels of volatile organic compounds (VOC)
pp. 39-39(1)
Authors: Worrilow K.C.; Huynh H.T.; Bower J.B.; Schillings W.; Peters A.J.

Importance of direct measurements of micro-drop temperature
pp. 39-40(2)
Authors: Langley M.; Del Marek; Nackley A.; Doody K.; Doody K.

Value of zygote morphology in a day 3 embryo transfer program
pp. 40-40(1)
Authors: Billay D.M.; Fleetham J.A.; Kenefick A.R.; Przybylski P.S.; Sullivan M.; Greene C.A.

Effect of osteopontin on mouse embryo development in vitro
pp. 40-41(2)
Authors: Behr B.; Shlomo I.B.; Dasig D.; Lyon J.; Polan M.L.; Wang H.

Morphology of human embryos and apoptosis, as measured by P53 expression, a protein marker
pp. 41-41(1)
Authors: Dubey A.K.; Nater C.; Sutherland M.L.; Peak D.; Hartog B.; Gindoff P.R.

MAP kinase phosphorylation in relation to cytoskeletal behavior in mouse mature oocytes after vitrification
pp. 41-41(1)
Authors: Hwan L.S.; Eun P.S.; Jin J.H.; Won C.S.; Pyung K.I.; Yul C.K.

News media reporting of multiple births
pp. 41-42(2)
Author: Letterie G.S.

Single blastocyst stage (blast) embryo transfer (ET) after in vitro fertilization (IVF): a prospective randomized trial
pp. 42-42(1)
Authors: Surrey E.; Gardner D.; Stevens J.; Minjarez D.; Leitz A.; Schoolcraft W.

Higher implantation and pregnancy rates with early luteal rescue in patients undergoing in vitro fertilization (IVF) with profound estradiol (E2) drop
pp. 42-42(1)
Authors: Lakkis D.; Nassar Z.; Birbick T.; Fakih M.

Natural cycle IVF/ICSI with late follicular phase GnRH-antagonist administration: results according to subfertility diagnosis
pp. 42-43(2)
Authors: Pelinck M.J.; Hoek A.; Arts E.; Simons A.; Vogel N.; Heineman M.J.

Serum estradiol positively predicts outcomes in patients doing IVF
pp. 43-43(1)
Authors: Blazar A.S.; Hogan J.; Frankfurter D.; Hackett R.; Keefe D.L.

The importance of genetic screening for oocyte donors
pp. 43-44(2)
Authors: Kump L.; Jansen V.; Baek K.; Styne A.; Licciardi F.

Use of recombinant hCG results in reduced IVF pregnancy rates compared to non-recombinant u-hCG
pp. 44-44(1)
Authors: Retzloff M.G.; Jackson K.V.; Fox J.H.; Ginsburg E.S.; Racowsky C.

Basal antral follicle number predicts IVF cycle pregnancy, cancellation, and ovarian responsiveness: a prospective study
pp. 44-44(1)
Authors: Frattarelli J.L.; Levi A.; Miller B.T.; Segars J.H.

Simultaneous vaginal oocyte retreival and laparascopic proximal occlusion of ultrasound visible hydrosalpinges improve the IVF outcome
pp. 44-45(2)
Authors: Sahebkashaf H.; Aghahosseini M.; Saidi H.; Ghalavand N.; Adel H.G.; Sahebkashaf S.

Pronuclear embryo transfer on day 1 versus cleavage stage embryo transfer on day 3: a prospective randomized trial
pp. 45-45(1)
Authors: Coskun S.; Jaroudi K.; Sieck U.; Alsufyan H.; Alhassan S.; Alkabra M.

Does intracytoplasmic sperm injection for unexplained low fertilization improve fertilization and pregnancy rates?
pp. 45-45(1)
Authors: Kuohung W.; Jackson K.V.; Racowsky C.; Ginsburg E.S.

Transfer of embryos to the mid- to lower uterine segment significantly improves implantation and pregnancy rates when compared to fundal embryo transfers
pp. 45-46(2)
Authors: Frankfurter D.; Trimarchi J.R.; Silva C.P.; Keefe D.

Recombinant follicle stimulating hormone (R-FSH) versus recombinant luteinizing hormone (R-LH) and R-FSH treatment in combination with cetrorelix after oral contraceptive programming in IVF/ICSI; a feasibility study
pp. 46-46(1)
Authors: van Loenen A.C.D.; Pirard C.; Donnez J.; Huirne J.A.F.; Schats R.; Lambalk C.B.

Performing embryo transfer under ultrasound guidance - a meta analysis of randomized trials
pp. 46-46(1)
Authors: Sallam H.N.; Saad-el-Din S.

Comparison of two different blastocyst grading systems and their impact on pregnancy, implantation, and multiple pregnancy rates: a randomized study
pp. 46-47(2)
Authors: Balaban B.; Isiklar A.; Alatas C.; Aksoy S.; Mumcu A.; Urman B.

Incidence of monozygotic twinning with blastocyst transfer compared to cleavage stage transfer
pp. 47-47(1)
Authors: Milki A.A.; Jun S.H.; Hinckley M.D.; Behr B.; Giudice L.C.; Westphal L.M.

A nationwide follow-up system of pregnancies and children conceived with assisted reproductive technologies
pp. 47-48(2)
Authors: Ramogida C.; France for 15 IVF centers

Blastocyst development on day 5 - A relationship to clinical pregnancy rate?
pp. 48-48(1)
Authors: McCaffrey C.; Adler A.; Berkeley A.S.; Grifo J.; Noyes N.; Krey L.C.

Elective single embryo transfer in fresh cycles
pp. 48-48(1)
Authors: Del Marek; Langley M.; Nackley A.C.; Doody K.M.; Doody K.J.

Influence of embryo transfer depth on pregnancy rate: fear the fundus
pp. 48-49(2)
Authors: Pope C.S.; Cook E.K.D.; Arny M.; Novak A.; Grow D.R.

Prolonged ovarian stimulation in ART cycles does not improve clinical pregnancy rates in poor responders
pp. 49-49(1)
Authors: Catherino W.H.; Leondires M.; McKeeby J.; Cruess D.; Segars J.H.; Armstrong A.

Comparison of IVF outcomes among women of different ethnic backgrounds
pp. 49-50(2)
Authors: Bendikson K.A.; Cramer D.W.; Hornstein M.D.

Elevated serum leptin: BMI ratio is associated with poorer IVF outcomes in women stimulated with human menopausal gonadotropin (hMG) versus pure FSH
pp. 50-50(1)
Authors: Brannian J.D.; Cederburg M.B.; Grasma N.M.; Hansen K.A.

Estradiol: oocyte ratio an early predictor of reduced ovarian reserve
pp. 50-50(1)
Authors: Montoya A.; Licciardi F.; Krey L.

Pregnancy outcome at the upper extreme of reproductive age: a comparison of two recipient groups
pp. 51-52(2)
Authors: Mor E.; Boostanfar R.; Saadat P.; Tourgeman D.E.; Slater C.C.; Paulson R.J.

Electronically excited species (EES) indices correlate with women's age and the chances of conception in ART
pp. 51-51(1)
Authors: Wiener - Megnazi Z.; Schnizer S.; Lahav - Baratz S.; Shiloh H.; Koifman M.; Dirnfeld M.

Randomized IVF trial of recombinant FSH versus FSH/LH: outcomes and pain perception
pp. 51-51(1)
Authors: Hines R.S.; Robinette L.D.; Sopelak V.M.; Cowan B.D.

The impact of peak follicular estradiol (E2) levels and its dramatic mid-luteal decline on the outcome of IVF-ET
pp. 52-52(1)
Authors: Friedler S.; Zimerman A.L.; Schachter M.; Raziel A.; Strassburger D.; El R.R.

The physician factor plays a significant role in the number of oocytes retrieved per case in a large assisted reproductive technology program
pp. 52-52(1)
Authors: Berger B.M.; Alper M.M.

The morphology of 2 pronuclear (2PN) embryos is related to the quality of day 3 embryos
pp. 52-53(2)
Authors: Shen S.; Wong C.; Ho K.; Telles T.L.; Fujimoto V.Y.; Cedars M.I.

Continuation of gonadotropin releasing hormone agonist during the luteal phase in in vitro fertilization patients: is it beneficial?
pp. 53-53(1)
Authors: Ozgur K.; Isikoglu M.; Seleker M.

Elevated efficacy of highly purified human menopausal gonadotropin (HP hMG) for intracytoplasmic sperm injection (ICSI): results of a prospective, randomized, controlled trial comparing HP hMG to recombinant follicle-stimulating hormone (r-hFSH)
pp. 53-53(1)
Authors: Kilani Z.; Dakkak A.; Ghunaim S.; Cognigni G.E.; Melappioni S.; Filicori M.

Luteal leuprolide administration does not impair FSH stimulated ovarian estradiol production
pp. 54-54(1)
Authors: Kowalik A.I.; Meyer W.; Lessey B.; Goselin R.; Fritz M.

FSH vs. FSH/LH does not impact upon blastocyst transfer pregnancy rates
pp. 54-54(1)
Authors: Straub R.; Chung P.H.; Choi J.M.; Spandorfer S.D.; Veeck L.L.; Rosenwaks Z.

Hormonal assessment of ovarian reserve during the cycle of stimulation: another benefit of GnRH antagonists
pp. 54-55(2)
Authors: Jurema M.W.; Bracero N.J.; Garcia J.E.

Double intrauterine inseminations (IUI) in clomiphene citrate (CC) cycles do not provide any advantage over single IUI: a randomized controlled trial
pp. 55-55(1)
Authors: Zeyneloglu H.B.; Bagis T.; Lembet A.; Ergin T.; Kuscu E.

Prospective randomized trial comparing the effects of 2.5 and 5.0mg of letrozole (LE) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation
pp. 55-55(1)
Authors: Biljan M.M.; Tan S.L.; Tulandi T.

A comparison between superovulation with FSH and a combination of FSH and letrozole
pp. 55-56(2)
Authors: Healey S.; Sylvestre C.; Tan S.L.; Tulandi T.; Biljan M.

The impact of isolated teratozoospermia on the cumulative life birth rate in IUI
pp. 56-56(1)
Authors: D'Hooghe T.; Vanderschueren D.; Bols P.; Wouters E.; Meuleman C.; Spiessens C.

Recombinant human luteinizing hormone for triggering follicular rupture: a dose finding study in ovulation induction (OI)
pp. 56-56(1)
Authors: Pierson R.A.; Olatunbosun F.A.; Baerwald A.R.; de Moustier B.; Saunders H.; Loumaye E.

Recombinant human albumin as protein source in culture media used for in vitro fertilization, a prospective randomized study
pp. 56-57(2)
Authors: Bungum M.; Humaidan P.; Bungum L.

The effect of different pronuclear patterns on the aneuploidy rate of cleavage stage embryos and subsequent blastocyst formation
pp. 57-57(1)
Authors: Urman B.; Balaban B.; Isiklar A.; Ercelen N.

Oocyte biopsy and microtubule turnover: a novel technique to assess oocyte aging
pp. 57-57(1)
Authors: Goud A.P.; Goud P.T.; Diamond M.P.; Hughes M.R.

Evaluation of aneuploidy rates in morphologically distinct classes of spermatozoa
pp. 58-58(1)
Authors: Christensen G.L.; Wilcox A.; Carrell D.T.

Genetically identical analyzable sperm-derived nuclei produced in enucleated mammalian eggs
pp. 58-58(1)
Authors: Willadsen S.; Munne S.; Schimmel T.; Cohen J.

First clinical application of comparative genomic hybridization (CGH) and polar body testing for preimplantation genetic diagnosis (PGD) of aneuploidy
pp. 58-59(2)
Authors: Wells D.; Escudero T.; Cekleniak N.; Hughes P.; Delhanty J.D.; Munne S.

Predictive value of sperm fish analysis on the outcome of PGD for translocations
pp. 59-59(1)
Authors: Munne S.; Escudero T.; Sandalinas M.; Chen S.

Fertilization rates and purity after MicroSort(R) separation of fresh or frozen-thawed human sperm
pp. 59-59(1)
Authors: Karabinus D.; Opanga C.; Deresh D.; Wiley S.; Blauer K.

Reconstruction of ooplasm recipient oocytes with cryopreserved-thawed donor microcytoplasts: influence on the microtubular spindle
pp. 59-60(2)
Authors: Goud P.T.; Goud A.P.; Dozortsev D.I.; Diamond M.P.

An emerging method of generating cDNA libraries from individual mouse blastocysts
pp. 60-60(1)
Authors: Liu H.-C.; He Z.; Rosenwaks Z.

Defining the population of spermatozoal RNAs in normal fertile men
pp. 60-60(1)
Authors: Ostermeier G.C.; Thompson K.; Diamond M.P.; Dix D.J.; Miller D.; Krawetz S.A.

In vitro development and differentiation of spermatogenic cells from testicular tissue of patients with azoospermia in a three dimensional (3D) culture system
pp. 60-61(2)
Authors: Bing Y.Z.; Aono F.; Kuwayama M.; Kato O.

The extent of nuclear DNA damage in ejaculated human spermatozoa impacts on blastocyst development after IVF
pp. 61-61(1)
Authors: Seli E.; Gardner D.K.; Schoolcraft W.B.; Moffatt O.; Sakkas D.

Negative effects of sperm nuclear DNA damage on the fertility potential of couples with idiopathic and male-factor infertility
pp. 61-61(1)
Authors: Saleh R.A.; Agarwal A.; Nada E.A.; El-Tonsy M.H.; Evenson D.P.; Larson K.

Do severely oligospermic patients benefit from using testicular sperm rather than ejaculated sperm with ICSI?
pp. 62-62(1)
Authors: Liotta D.; Hariprashad J.; Cook C.; Schlegel P.; Zaninovic N.; Veeck L.

Lower sperm aneuploidy rate is associated with a higher pregnancy rate in unselected patients undergoing intracytoplasmic sperm injection
pp. 62-62(1)
Authors: Calogero A.E.; Burrello N.; Grazioso C.; Adele De Palma; Torrisi C.; D'Agata R.

In-vitro maturation (IVM) of fresh and frozen-thawed testicular sperm in non-obstructive azoospermia (NOA) improves ICSI outcomes
pp. 62-63(2)
Authors: Khotari N.; Dandekar P.; Dickstein S.; Wong D.; Wu B.; Gelety T.

Fluorescence ''in situ'' hybridization (FISH) analysis of chromosomal abnormalities in testicular and epididymal spermatozoa
pp. 63-63(1)
Authors: Rodrigo L.; Rubio C.; Simon C.; Remohi J.A.; Pellicer A.; Gil-Salom M.

False-positive Y chromosome microdeletion in a fertile male
pp. 63-64(2)
Authors: Thornhill A.R.; Guenther A.J.; Barbarotto G.M.; Snow K.

Utilization rate and fertility outcome of cryopreserved sperm from oncological patients: American experience
pp. 64-64(1)
Authors: Ranganathan P.; Agarwal A.; Khayal S.; Kattal N.

A randomized prospective study of misoprostol alone or combined with mifepristone for treatment of first trimester spontaneous abortion
pp. 64-64(1)
Authors: Machtinger R.; Stockheim D.; Goldenberg M.; Soriano D.; Atlas M.; Seidman D.S.

Wet versus dry intravaginal misoprostol application for treatment of early pregnancy failure
pp. 64-65(2)
Authors: Gilles J.; Creinin M.M.; Barnhart K.T.; Westhoff C.; Frederick M.M.; Zang J.

Short-term outcomes of uterine artery embolization: early results of the national CIRREF FIBROID registry.
pp. 65-65(1)
Author: Myers E.

Treatment with the GnRH agonist (GnRHa) deslorelin (D) and low-dose add-back estradiol (E2) is effective in reducing pain, bleeding and uterine volume (UV) while maintaining bone mineral density (BMD) in women with symptomatic uterine fibroids (UF)
pp. 65-66(2)
Authors: Daniels A.; Pike M.C.; Balance Pharmaceuticals Uterine Fibroids Study Group; Daniels J.R.; Spicer D.V.

The utility of chlamydia trachomatis titer determination as a screening tool for the prediction of tubo-peritoneal disease
pp. 66-66(1)
Authors: Saadat P.; Aliabadi T.; Tourgeman D.E.; Mor E.; Slater C.C.; Paulson R.J.

Infertility treatment in women over 40 years old: is controlled ovarian hyperstimulation/ intrauterine insemination a viable option?
pp. 66-66(1)
Authors: Spandorfer S.; Cioczek A.; Chung P.; Rosenwaks Z.

The desire of infertility patients for multiple gestations-do they know the risks?
pp. 67-67(1)
Authors: Ryan G.L.; Zhang S.; Dokras A.; Van Voorhis B.J.

Endometrial dating revisited: a randomized systematic study of secretory phase histologic characteristics in normally cycling fertile women
pp. 67-67(1)
Authors: Murray M.J.; Meyer W.R.; Lessey B.A.; Zaino R.J.; Novotny D.B.; Fritz M.A.

Folliculogenesis revisited: characteristics of ovarian follicular waves during the menstrual cycle
pp. 67-68(2)
Authors: Baerwald A.R.; Adams G.P.; Pierson R.A.

Use of Oxiplex(R) to inhibit adhesion reformation in a rabbit adhesiolysis model
pp. 68-68(1)
Authors: Berg R.A.; Rodgers K.E.; Cortese S.; Espinoza T.; Roda N.; diZerega G.S.

Incidence of varicocele in children and adolescents: a population-based study on 1200 young Bulgarian males
pp. 68-68(1)
Authors: Saleh R.A.; Agarwal A.; Oder M.; Hubaveshki S.; Tomova A.; Kumanov P.

A prospective double blind placebo controlled cross over trial of carnitine therapy in selected cases of male infertility
pp. 68-69(2)
Authors: Lombardo F.; Gandini L.; Agarwal A.; Sgro P.; Dondero F.; Lenzi A.

Post-ejaculatory urinalysis in fertile and infertile men
pp. 69-69(1)
Authors: Boyle K.E.; Sigman M.; Jarow J.P.

Outcomes for vasovasostomy with bilateral intravasal azoospermia
pp. 69-69(1)
Authors: Kolettis P.N.; Burns J.R.

DNA double strand breaks and apoptosis in human sperm: effects of donor age
pp. 69-70(2)
Authors: Singh N.P.; Muller C.H.; Berger R.E.

A novel technique of spermatogonial stem cell isolation
pp. 70-70(1)
Authors: Brugh V.M.; Parker M.A.; Murthy L.R.; Lipshultz L.I.; Lamb D.J.

Is male germ cell aplasia treatable?
pp. 70-71(2)
Authors: Takeuchi T.; Rosenwaks Z.; Palermo G.D.

Experience with testis FNA mapping and microdissection (M & M) in difficult nonobstructive azoospermia cases
pp. 71-71(1)
Authors: Jad A.M.; Turek P.J.

Patients chose Gonal-F multidose more often than follistim or Gonal-F ampules because of perceived physician recommendation
pp. 71-71(1)
Authors: DySard L.A.; Kowalik A.

Characteristics of successful human chorionic gonadotropin (hCG) administration in assisted reproduction
pp. 71-72(2)
Authors: Markle R.L.; King P.J.; Martin D.B.; Kutteh W.H.; Ke R.W.

Severity and duration of symptoms in the luteal phase during gonadotropin treatment
pp. 72-72(1)
Author: Barrow S.R.

Repeated cycles of ovarian stimulation in oocyte donors: does it impact outcome?
pp. 72-72(1)
Authors: Gutmann J.N.; Gocial B.; Graves K.

Frozen blastocyst embryo-transfer: the impact of the duration of estradiol induced endometrial stimulation on cycle outcome
pp. 72-72(1)
Authors: Materia D.; Naik D.; Hosid S.; Levi A.; Armstrong A.; McKeeby J.

Perceptions of age and fertility: a survey of reproductive healthcare providers
pp. 72-73(2)
Authors: Hammond K.R.; Rocconi R.P.; Steinkampf M.P.

The influence of hyperandrogenism, obesity, and infertility on the sexual and relationship satisfaction of women with polycystic ovary syndrome
pp. 73-73(1)
Authors: McCook J.G.; Thatcher S.S.

Nurse counselling prior to an endometrial biopsy in women with recurrent miscarriage: a randomized controlled trial
pp. 73-74(2)
Authors: Houlihan E.M.; Stephenson M.D.

Potential for multiple loss during IVF treatment of infertile couples: a mid-range nursing theory
pp. 74-74(1)
Author: Davol H.T.

Assisted reproduction for HIV (human immunodeficiency virus) infected patients: current practices and attitudes of paramedical staff
pp. 74-74(1)
Authors: Copeland J.; Fluker M.; Yuzpe A.

Genes differentially expressed in fibroids and myometrium by cDNA microarray
pp. 74-75(2)
Authors: Vollenhoven B.J.; Weston G.C.; Manuelpillai U.; Rogers P.

Microarray detection of differential gene expression within the endometrium following exposure to spermatozoa
pp. 75-75(1)
Authors: Williams S.C.; Sladek R.; Oehninger S.; Gosden R.; Gibbons W.E.

Genes provide insight into the mechanisms of the primordial-primary follicle transition
pp. 75-75(1)
Authors: Lee K.-A.; Park C.-E.; Ko J.-J.; Lee W.-S.; Lee S.-H.; Cha K.-Y.

Gene silencing in mouse embryos using short interfering oligoribonucleotide-based double-stranded constructs
pp. 75-76(2)
Authors: Malter H.E.; Steuerwald N.; Cohen J.

Analysis of human preimplantation embryos and aging oocytes by cDNA microarrays
pp. 76-76(1)
Authors: Dobson A.T.; Abeyta M.J.; Haqq C.; Pera R.A.R.

Assessment of parthenogenetic activation of human metaphase II oocytes for stem cell derivation
pp. 76-77(2)
Authors: Wininger J.D.; Huang S.; Massey J.B.; Lei J.; Lin H.

Behavior of somatic nuclei in meiotic cytoplasm
pp. 77-77(1)
Author: Mrazek M.

Germinal vesicle xeno-transfer between mouse and human oocytes: A model to study ooplasmic influences on meiotic division
pp. 77-77(1)
Authors: Liu H.; Krey L.C.; Zhang J.; Chang H.; Grifo J.

Analysis of multiple genes governing chromosome segregation, the cell cycle and apoptosis in human preimplantation embryos: Identification of new genetic indicators of embryo viability
pp. 77-78(2)
Authors: Wells D.; Bermudez M.G.; Cohen J.; Delhanty J.D.

Mitochondrial dysfunction leads to telomere shortening, apoptosis and genomic instability: Toward a unified theory of reproductive aging
pp. 78-78(1)
Authors: Keefe D.L.; Liu L.; Trimarchi J.

Recovery of reproductivity after grafting of cryopreserved germinative tissue in sheep subjected to radiotherapy
pp. 78-79(2)
Authors: Almodin C.G.; Minguetti V.C.; Fuck E.T.; Ceschin A.P.; Meister H.; Ferreira J.O.A.R.

Transplantation of intact frozen-thawed mammalian ovary with micro-vascular anastomosis
pp. 79-79(1)
Authors: Bedaiwy M.A.; Jeremias E.; Gurunluoglu R.; Hussein M.R.; Biscotti C.; Falcone T.

A randomized controlled trial of sublingual misoprostol for cervical priming before hysteroscopy
pp. 79-79(1)
Authors: Bisharah M.; Alfozan H.; Tulandi T.

Oral misoprostol prior to operative hysteroscopy does not enhance cervical dilation or improve operative time: A prospective randomized, double blind, placebo-controlled trial
pp. 79-80(2)
Authors: Preen A.E.; McKeeby J.L.; Catherino W.; Alvero R.J.

Significant clinical improvement following non-invasive transcutaneous thermal ablation of uterine fibroids by magnetic-resonance-imaging-guided high-focus ultrasound
pp. 80-80(1)
Authors: Rabinovici J.; Inbar Y.; Zalel Y.; Oelsner G.; Mashiach S.; Itzchak Y.

Fertility preservation in breast cancer patients: In vitro fertilization and embryo cryopreservation after ovarian stimulation with tamoxifen
pp. 80-80(1)
Authors: Oktay K.H.; Buyuk E.; Davis O.K.; Rosenwaks Z.

Quantitative microinjection of sugars into mouse eggs and their effect on static osmometric behavior and development
pp. 81-81(1)
Authors: Eroglu A.; Bhowmick P.; Lawitts J.; Wright D.; Toner M.; Toth T.

Evaluation of meiotic spindles in thawed oocytes after vitrification using polarized light microscopy
pp. 81-81(1)
Authors: Chen C.-K.; Wang C.-W.; Horng S.-G.; Soong Y.-K.

Co-Culture of monkey ovarian tissue with fetal mouse fibroblasts and FSH increases survival with vitrification and slow rate freezing
pp. 81-82(2)
Authors: Lee D.M.; Yeoman R.; Wolf D.

Chromosomal abnormalities in embryos derived from TESE in Y-deleted and non-Y-deleted men
pp. 82-82(1)
Authors: Silber S.J.; Oates R.D.; Escudero T.; Sadowy S.; Kilani Z.; Munne S.

Towards a better understanding of chromosomal mosaicism in human preimplantation embryos
pp. 82-82(1)
Authors: Katz M.G.; Trounson A.O.; Cram D.S.

Development of a mouse model for ooplasmic transplantation
pp. 83-83(1)
Authors: Malter H.E.; Schimmel T.; Cohen J.

Prospective randomized study to compare the effect of recombinant LH (rec LH) supplementation in women undergoing assisted reproduction with GnRH agonist (GnRHa) down-regulation and stimulation with recombinant FSH (rec FSH)
pp. 83-83(1)
Authors: Humaidan P.H.; Bungum L.; Bungum M.; Andersen C.Y.

A significant increase in the implantation rate with the asynchronous transfer of cryopreserved cleavage-stage embryos
pp. 83-84(2)
Authors: Mayer J.F.; Jones E.L.; Lacey D.; Gibbons W.E.; Oehninger S.C.; Muasher S.J.

Identification of the male pronucleus during fertilization of artificial oocytes
pp. 84-84(1)
Authors: Takeuchi T.; Katagiri Y.; Veeck L.; Rosenwaks Z.; Palermo G.D.

Intrauterine inseminations without twins: A new milder ovarian stimulation
pp. 84-85(2)
Authors: Alagna F.; Ragni G.; Brigante C.; Riccaboni A.; Colombo M.; Crosignani P.G.

Pharmacoeconomic modeling of Gonal-F versus clomiphene citrate in ovulation induction & intra uterine insemination for women with normal ovulation
pp. 85-85(1)
Authors: McVeigh E.; Auray J.-P.; Lass A.; Beresniak A.

Significant improvement of intrauterine insemination pregnancy rates following platelet-activating factor treatment
pp. 85-85(1)
Authors: Massey J.B.; Toledo A.A.; Mitchell-Leef D.; Slayden S.M.; Cano J.A.; Roudebush W.E.

Comparison between the effect of 10.000 IU and 5.000 IU of hCG, on the incidence of severe ovarian hyperstimulation syndrome
pp. 85-86(2)
Authors: Valle M.; Sampaio M.A.C.; Lemgruber M.; Geber S.

Predictive value of polymorphonuclear granulocytes in relation to growth of microorganisms in semen
pp. 86-86(1)
Authors: Lu L.; Look C.; Sanchez X.M.; Lacsamana J.; Macanas E.; Krey L.C.

Intact progesterone receptors are essential to counteract the proliferative effect of estrogen in a transgenic mouse model of endometriosis
pp. 86-86(1)
Authors: Fang Z.; Yang S.; Lydon J.P.; Gurates B.; Tamura M.; Bulun S.

Differential regulation of progesterone receptor (PR) by Tcdd in isolated human endometrial stromal cells versus stromal-epithelial co-cultures
pp. 86-87(2)
Authors: Igarashi T.M.; Bruner-Tran K.; Yeaman G.; Eisenberg E.; Osteen K.

Altered stromal-epithelial cell communication may contribute to reduced progesterone sensitivity in endometriosis
pp. 87-87(1)
Authors: Bruner-Tran K.L.; Yoder C.; Eisenberg E.; Osteen K.G.

Anti-angiogenesis treatment with thalidomide in endometriosis: A pilot study
pp. 87-87(1)
Authors: Scarpellini F.; Sbracia M.; Lecchini S.; Scarpellini L.

Comparative immunohistochemical studies of endometriosis lesions and endometriotic cysts
pp. 87-88(2)
Authors: Nezhat F.; Cohen C.; Rahaman J.; Gretz H.; Kalir T.

Heparanase-1 expression in endometrium during menstrual cycle in healthy control women and in women with endometriosis
pp. 88-88(1)
Authors: Ding J.; Xu X.; Shen J.; Braun D.P.; Rana N.; Dmowski W.P.

Intense focal expression of de novo synthesized haptoglobin by subluminal endometrial stroma correlates with the window of implantation in women with endometriosis
pp. 88-88(1)
Authors: Sharpe-Timms K.L.; Zimmer R.L.; Ricke E.A.

Tumor necrosis factor alpha promoted interleukin-8-induced proliferation of endometriotic stromal cells via nuclear factor-kB activation
pp. 89-89(1)
Authors: Harada T.; Iwabe T.; Sakamoto Y.; Taniguchi F.; Yoshida S.; Terakawa N.

Effect of Interleukin-6 and Interleukin-8 on the in vitro adhesion of endometrial epithelial cells to mesothelial cells
pp. 89-89(1)
Authors: Debrock S.; Destrooper B.; Vander Perre S.; Hill J.A.; D'Hooghe T.

CD10 immunohistochemical staining enhances the pathological detection of endometriosis
pp. 89-90(2)
Authors: Nahari C.P.; Feldman A.L.; Sinaii N.; Merino M.J.; Stratton P.; Nieman L.K.

The antral follicle count (AFC) correlates with metaphase II oocytes and ART cycle outcome: an update
pp. 90-90(1)
Authors: Fisch J.D.; Sher G.

Transcervical tubal catheterization (TTC) is the treatment of choice for infertile women with proximal tubal obstruction: an experience with 1010 fallopian tubes
pp. 90-90(1)
Authors: Tur-Kaspa I.; Moscovici O.; Meltzer S.; Peled R.; Rabinson J.; Segal S.

Endometrial sampling during sonohysterography (SHGes) in the management of abnormal uterine bleeding
pp. 90-91(2)
Authors: Leone F.P.G.; Lanzani C.; Ferrazzi E.

Are increased estradiol levels the only responsible factor of increased uterine perfusion in patients submitted to controlled ovarian hyperstimulation? The possible role of androgens
pp. 91-91(1)
Authors: Ajossa S.; Guerriero S.; Paoletti A.M.; Bargellini R.; Orru M.; Melis G.B.

Implantation site assessment analyzed using 3-dimensional transvaginal ultrasonography: the embryo does not travel far
pp. 91-91(1)
Authors: Grunfeld L.; Sandler B.; Mukherjee T.; Copperman A.B.

A prospective study to evaluate the efficacy of Three- and Two-Dimensional sonohysterography in women with intrauterine lesion
pp. 91-92(2)
Authors: Sylvestre C.V.; Child T.J.; Tan S.L.; Tulandi T.

3-D ovarian changes during the fertility period: from age 20 to 45 years old
pp. 92-92(1)
Authors: Zohav E.; Segal O.; Meltzer S.; Rabinson J.; Segal S.; Tur-Kaspa I.

Does ultrasonographic measurement of uterine embryo transfer material predict clinical pregnancy?
pp. 92-92(1)
Authors: Fakih M.H.; Grossman M.P.; Nassar Z.; Abuzeid M.I.; Salem H.H.; Myers D.L.

3-D endometrial volume on the day of ET and IVF outcome
pp. 92-93(2)
Authors: Tur-Kaspa I.; Segal O.; Meltzer S.; Rabinson J.; Segal S.; Zohav E.

3-dimensional ultrasound as a single step for evaluation of infertile women
pp. 93-93(1)
Authors: Ali A.F.M.; Hamed W.M.; Shalabi H.S.; AbdelRahman A.E.

Relationship of predominant histologic pattern at testis biopsy to outcome following in vitro fertilization with intracytoplasmic sperm injection (IVF/ICSI) in men with azoospermia
pp. 93-93(1)
Authors: Sparks S.S.; Schrepferman C.G.; Brugh V.M.; Lamb D.J.; Lipshultz L.I.

An abnormal sperm protamine 1/protamine 2 (P1/P2) ratio is associated with diminished in vitro fertilization capability
pp. 93-94(2)
Authors: Carrell D.T.; Wilcox A.L.; Liu L.; Hatasaka H.H.; Jones K.P.; Peterson C.M.

Functional analysis of sperm obtained from electroejaculation and penile vibratory stimulation: Correlation to success with intrauterine insemination
pp. 94-94(1)
Authors: Ohl D.A.; Wang X.; Schuster T.G.; Keller L.M.; Smith G.D.

Comparison of the motility of testicular sperm cultured at different culture conditions: Human follicular fluid (HFF) temperatures
pp. 94-94(1)
Authors: Su S.J.I.; Ohn S.J.; Kyung C.M.; Sik L.W.; Pyung K.I.; Kyu C.T.

A neural computational model of ICSI outcomes from sperm source and other features
pp. 94-95(2)
Authors: Land S.; Murthy L.; Lamb D.; Lipshultz L.; Ross L.; Niederberger C.

Correlation of nuclear factor kappa B (NFKB) with sperm quality and clinical diagnoses in infertile men
pp. 95-95(1)
Authors: Ranganathan P.; Kattal N.; Moustafa M.H.; Sharma R.K.; Thomas A.J.; Agarwal A.

DNA microarray analysis of gene expression of spermatogenesis in mouse
pp. 95-95(1)
Author: Li W.

Mutation analysis of the GREAT (G Protein-Coupled receptor affecting testis descent) gene in cryptorchid patients
pp. 96-96(1)
Authors: Kamat A.A.; Bogatcheva N.; Agoulnik A.I.

Estradiol induces apoptosis in endothelial cells by up-regulating Fas/Fas ligand pathway
pp. 96-96(1)
Authors: Seli E.; Kayisli U.A.; Selam B.; Berkkanoglu M.; Arici A.

Analysis of endometrial RNA transcripts before and after treatment with raloxifene, tamoxifen, conjugated estrogen or placebo using polymerase chain reaction
pp. 96-97(2)
Authors: Vardy M.D.; Lindsay R.; Loose-Mitchell D.S.; Shipley G.L.; Nieves J.; Cosman F.

The hypothalamic GnRH pulse generator is altered in ovulatory, premenopausal women: evidence from 24hr pulsatile LH studies
pp. 97-97(1)
Authors: Reame N.; Lukacs J.; Ansbacher R.; Chillimigras J.; Padmanabhan V.

Effects of hormone replacement therapy (HRT) on bone mineral density (BMD) in patients with or without Col1A1 Sp1 binding site polymorphism
pp. 97-97(1)
Authors: Simsek M.; Cetin Z.; Taskin O.; Bilgen T.; Luleci G.; Trak B.

Quantification of menstrual blood loss
pp. 97-97(1)
Authors: Gupta D.; Santoro N.

Buccal estrogen in toothpaste study: systemic absorption of estradiol in postmenopausal or surgically menopausal women when administered as a component in toothpaste
pp. 98-98(1)
Authors: Chandrasekhara D.S.; Ali V.; Prost H.M.; Nader-Estekhari S.

Effect of two commonly prescribed oral hormone replacement formulations on serum androgen levels
pp. 98-98(1)
Authors: Uzelac P.S.; Shoupe D.; Zhang C.; Chang L.; Stanczyk F.Z.

The effects of different hormone replacement treatment regimens on tear function, intraocular pressure and lens opacity
pp. 98-99(2)
Authors: Uncu G.; Avci R.; Kaymaz C.; Uncu Y.; Develioglu O.

Decreased libido in women in the late reproductive years
pp. 99-99(1)
Authors: Gracia C.R.; Sammel M.D.; Liu L.; Hollander L.; Freeman E.W.

Tibolone in postmenopausal women with systemic lupus erythematosus
pp. 99-99(1)
Authors: Wieser F.; Stummvoll G.; Egarter C.; Huber J.; Smolen J.; Graninger W.

Effect of cryopreservation on mitochondrial membrane potential in human oocytes
pp. 99-100(2)
Authors: Jones A.E.; Davis P.; Toledo A.A.; Van Blerkom J.

The effect of anisosmotic conditions on the morphology of the metaphase II spindle of human oocytes, and its relevance to cryopreservation
pp. 100-100(1)
Authors: Mullen S.F.; Broermann D.C.; Jenkins C.L.; Johnson C.A.; Critser J.K.

Low temperature storage of primate embryonic stem cell derived neural precursor cells
pp. 100-101(2)
Authors: Yeoman R.R.; Kuo H.-C.; Pau F.; Wolf D.

Derivation of insulin-producing cells from non-human primate embryonic stem (ES) cells
pp. 101-101(1)
Authors: Kuo H.-C.; Nauert B.; Lester L.; Wolf D.

Modification of culture media improves blastocyst formation of poor quality embryos, but is this a good thing?
pp. 101-101(1)
Author: Hardy K.

Sex hormones affect adipogenesis
pp. 101-102(2)
Authors: Swiersz L.M.; Yun Z.; Giaccia A.

Effects of gonadotropin-releasing hormone (GnRH)-I and -II on regulating the urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in cultured human extravillous cytotrophoblasts
pp. 102-102(1)
Authors: Chou C.S.; Shalev E.; Zhu H.E.; MacCalman C.D.; Leung P.C.K.

Preimplantation development of germinal vesicle recipient oocytes
pp. 102-103(2)
Authors: Takeuchi T.; Rosenwaks Z.; Palermo G.D.

Analysis of the expression of polycomb group (Pc-g) genes in human ovarian follicles, oocytes and preimplantation embryos
pp. 103-103(1)
Authors: Huntriss J.; Hinkins M.; Picton H.

Expression of apoptosis-related proteins in human fragmented embryos
pp. 103-103(1)
Authors: Song H.; Kim M.; Kim J.; Jung B.; Shim J.-o.; Kang E.-h.

Profound gonadotropin suppression in adult women with McCune-Albright syndrome
pp. 103-104(2)
Authors: Murdock C.; Collins M.; Robey P.; Nieman L.

Expression of uterine receptivity markers in natural cycles and in cycles with hormonal substitution: Preliminary results of 7 women with Tubal-Factor infertility
pp. 104-104(1)
Authors: Oborna I.; Fingerova H.; Novotny R.; Havelka P.; Kubinyiova M.; Agarwal A.

Endocrine and clinical profiles of controlled ovarian stimulation (COS): improved features in human menopausal gonadotropin (hMG) vs. recombinant human follicle-stimulating hormone (r-hFSH) treatment
pp. 104-105(2)
Authors: Filicori M.; Cognigni G.E.; Melappioni S.; Tabarelli C.; Ferlini F.; Bernardi S.

Lower serum levels of inhibin A and pro-C during the luteal phase after triggering oocyte maturation with gonadotropin releasing hormone (GnRH) agonist in comparison to human chorionic gonadotropin (hCG): possible relevance for the prevention of ovarian hyperstimulation (OHSS)
pp. 105-105(1)
Authors: Nevo O.; Eldar-Geva T.; Kol S.; Itskovitz-Eldor J.

Daily low dose recombinant hCG and low dose recombinant FSH: a novel treatment for hypogonadotropic hypogonadism
pp. 105-105(1)
Authors: Doody K.M.; Nackley A.C.; Doody K.J.

A comparison of the effect of metformin and rosiglitazone on insulin action and secretion in women with polycystic ovary syndrome
pp. 105-106(2)
Authors: Thyer A.C.; Brzyski R.; Easton C.; Schenken R.

Extracellular matrix-activin interactions in granulosa cell growth and apoptosis
pp. 106-106(1)
Authors: Buyuk E.; Oktay M.; Giancotti F.; Rosenwaks Z.; Oktay K.H.

High levels of apoptosis in ejaculated spermatozoa from infertile men
pp. 106-107(2)
Authors: Moustafa M.H.; Saleh R.A.; Oder M.; Thomas A.J.; Abdel-Hafez M.A.; Agarwal A.

Synchronization of recipients for embryo transfer: a novel method using a gonadotropin releasing hormone (GnRH) antagonist in rhesus monkeys
pp. 107-107(1)
Authors: Thormahlen S.L.; Stouffer R.L.; Wolf D.P.; Zelinski-Wooten M.B.

Association of basal follicle stimulating hormone (FSH) levels with FSH receptor variants in subfertile women with normal menstrual cycle: implications for ovarian sensitivity to FSH
pp. 107-108(2)
Authors: Lambalk C.B.; Benjamins T.; Harms P.; van Montfrans J.M.; Gromoll J.; Simoni M.

Are heat shock proteins acting as modulators of pre-implantation mouse embryo development and apoptosis?
pp. 108-108(1)
Authors: Esfandiari N.; Falcone T.; Agarwal A.; Goldberg J.M.; Nelson D.R.; Sharma R.K.

The gene for regeneration and tolerance factor is expressed by human endometrial cells particularly during the secretory phase of the cycle and is regulated by Interleukin-1
pp. 108-108(1)
Authors: Vigano' P.; Lattuada D.; Mangioni S.; Lauletta R.; Vignali M.; Di Blasio A.M.

The anthrax vaccine does not affect semen parameters, embryo quality, or pregnancy outcome in couples with a vaccinated male military service member
pp. 108-109(2)
Authors: Catherino W.H.; Levi A.; Leondires M.; Segars J.H.; Alvero R.; McKeeby J.

Changes in cytokine expression in peripheral leukocytes, detected by microarray analysis, in the secretory vs proliferative phase of the menstrual cycle
pp. 109-109(1)
Authors: Lathi R.B.; Tulac S.; Lobo S.C.; Huang S.-T.J.; Giudice L.C.

Expression of pre-apoptotic and proliferative molecules in human myometrium and leiomyomata throughout the menstrual cycle
pp. 109-110(2)
Authors: Kayisli U.A.; Berkkanoglu M.; Senturk L.M.; Arici A.

Concentration of leukemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation
pp. 110-110(1)
Authors: Ledee-Bataille N.; Olivennes F.; Frydman R.; Taupin J.-L.; Kadoch J.; Chaouat G.

Does autologous transplantation of cryopreserved ovary result in induction of anti-ovarian antibodies?
pp. 110-110(1)
Authors: Esfandiari N.; Bedaiwy M.A.; Agarwal A.; Jeremias E.; Sharma R.K.; Falcone T.

The immune environment in human endometrium during the window of implantation
pp. 110-111(2)
Authors: Lobo S.C.; Huang S.-T.J.; Giudice L.C.

Intravenous immunoglobulin G (IVIG) is associated with markedly improved IVF outcome in patients with elevated peripheral natural killer cell activity (NKa+) and prior unexplained IVF failure
pp. 111-111(1)
Authors: Fisch J.D.; Sher G.; Maassarani G.; Danner L.

Implantation failure after technically successful IVF: evidence of four different abnormal cytokine expression profiles that might explain inadequate uterine receptivity
pp. 111-111(1)
Authors: Ledee-Bataille N.; Frydman R.; Dubanchet S.; Durand-Gasselin I.; Taupin J.-l.; Chaouat G.

TGF-Beta 1/Beta 2 mRNA ratio in normally healed peritoneum same as in uninjured tissue
pp. 112-112(1)
Authors: Freeman M.L.; Saed G.M.; Diamond M.P.

One-Year followup results of a randomized, multi-center clinical study of the NovaSure&unknown; impedance controlled endometrial ablation system
pp. 112-112(1)
Author: Galen D.I.

Chance of adhesion formation after laparoscopic salpingoovolysis. Is there any place for second look laparoscopy?
pp. 112-112(1)
Authors: Alborzi S.; Motazedian S.; Parsanezhad M.E.

Dichloroacetate (DCA) significantly increase the expression of inducible nitric oxide synthase (iNOS) in human fibroblasts of adhesion tissues but not in normal peritoneium
pp. 112-113(2)
Authors: Saed G.M.; Diamond M.P.

Surgeon experience and surgical level of complexity strongly predict success of failure of laparoscopic approach
pp. 113-113(1)
Authors: Milad M.P.; Sokol A.; Chuang K.

Factors affecting the reproductive outcome after microsurgical tubal ligation reversal
pp. 113-113(1)
Author: Hanafi M.M.

Matrix metalloproteinase (MMP-1, MMP-2), and tissue inhibitor for metalloproteinase (TIMP-1) expression by human peritoneal mesothelial cells: effect of fibrin sealant
pp. 113-114(2)
Authors: Saed G.M.; Diamond M.P.

4% icodextrin solution has no adverse effect on surgical wound healing in rabbits
pp. 114-114(1)
Authors: Verco S.; Rodgers K.; diZerega G.

Hysteroscopic selective tubal cannulation under direct laparoscopic visualization revisited
pp. 114-114(1)
Authors: Abdallah M.A.; Nakajima S.T.; Eblen A.C.

Plasminogen activator modulation by the PROACT&unknown; system
pp. 114-115(2)
Authors: Ivarsson M.-L.; Holmdahl L.; Falk P.; Diamond M.P.

Intrauterine insemination (IUI), in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in human immunodeficiency virus (HIV) serodiscordant couples: results and perspectives
pp. 116-116(1)
Authors: Quintana R.; Tiveron M.; Garcia F.; Kopcow L.; Bisioli C.; Young E.

Successful healthy birth in vitro maturation of human immature oocytes . Attempt of the unstimulated menstrual cycles and Frozen-Thawed embryo cycles
pp. 116-116(1)
Authors: Fukunaga N.; Kyono K.; Haigo K.; Chiba S.; Nakajo Y.; Fuchinoue K.

Paraoxonase (PON) activity as a marker of oxidative stress in women with endometriosis, undergoing in-vitro fertilization
pp. 116-117(2)
Authors: Zoneraich N.; Shanti A.; Richlin S.S.; Kavtaradze N.; Parthasarthy S.; Murphy A.A.

Transvaginal route seems to be the safest way for early multifetal pregnancy reduction
pp. 117-117(1)
Authors: Ozgur K.; Isikoglu M.

Infectious diseases and genetic disorders found in the routine screening in an ovum donation programme: Experience from 10 years Follow-Up
pp. 117-117(1)
Authors: Zuzuarregui J.L.; Meseguer M.; Garrido N.; Pellicer A.; Simon C.; Remohi J.

Does increased body mass index (BMI) have an adverse effect on uterine receptivity?
pp. 117-118(2)
Authors: Wattanakumtornkul S.; Damario M.A.; Tummon I.S.

Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation program
pp. 118-118(1)
Authors: Ledee-Bataille N.; Olivennes F.; Fernandez H.; Chaouat G.; Frydman R.

Which aspects of embryo transfer technique impact IVF outcome in a homogeneous good prognosis population?
pp. 118-118(1)
Authors: Ashby R.K.; Jackson K.V.; Racowsky C.; Ginsburg E.S.

Clinical outcomes and cycle characteristics of donor oocyte cycles using the GnRH analogues ganirelix or leuprolide
pp. 118-119(2)
Authors: Kelly M.P.; Shapiro D.; Tillotson D.; Batzer F.

Relationship between serum LH and IVF outcome in cycles with a GnRH antagonist (Cetrorelix)
pp. 119-119(1)
Authors: Bosch E.; Valencia I.; Crespo J.; Simon C.; Remohi J.; Pellicer A.

Sperm capacitation index (SCI) predicts pregnancy outcome with controlled ovarian hyperstimulation (COH) + intrauterine insemination (IUI)
pp. 119-119(1)
Authors: Merryman D.C.; Stringfellow S.E.; Dalton K.E.; Houserman V.L.; Long C.A.; Honea K.L.

Assessment of endometrial leukemia inhibitory factor (LIF) levels by uterine flushing at the time of egg retrieval in IVF-ET
pp. 119-120(2)
Authors: Olivennes F.J.; Ledee-Bataille N.; Samama M.; Taupin J.-L.; Chaouat G.; Frydman R.

Thin endometrial strip does not predict poor IVF treatment outcome following embryo transfer on day 5
pp. 120-120(1)
Authors: Chen C.-H.; Zhang X.; Confino E.; Milad M.; Kazer R.R.

Initiation of a GnRH antagonist in IVF cycles in which the lead follicle is greater than 14 mm
pp. 120-120(1)
Authors: Klipstein S.; Lalwani S.; Timmreck L.; Alper M.; Reindollar R.H.

Establishing cut-off values for sperm parameters in order to predict fertilization outcome in vitro
pp. 120-121(2)
Authors: Zavos P.M.; Kaskar K.; Zarmakoupis-Zavos P.N.

Development of a collaborative donor egg recruitment program among three reproductive endocrinology centers
pp. 121-121(1)
Authors: Price T.M.; Hurst B.S.; Wing R.L.

Lower implantation rate with downward displacement of ultrasonograpic based echogenic drop following uterine embryo transfer
pp. 121-121(1)
Authors: Nassar Z.; Grossman M.; Lakkis D.; Ghutmi W.; Massaad Z.; Fakih M.

Assessing the clinical utility of in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) in human immunodeficiency virus-1 (HIV-1) serodiscordant couples: report of 103 consecutive cycles
pp. 122-122(1)
Authors: Pena J.E.; Thornton M.H.; Ruman J.; Klein J.; Kavic S.; Sauer M.V.

Antagonist versus agonist in IVF cycles with ovarian resistance
pp. 122-122(1)
Authors: Gleicher N.; Villafana D.; Skoog W.; Vidali A.

Monozygotic twinning is not associated with zona pellucida micromanipulation but increases with high order multiple pregnancies
pp. 122-123(2)
Authors: Elizur S.; Shulman A.; Levron J.; Sivan E.; Farber B.; Dor J.

The effect of coasting on IVF/ICSI outcome
pp. 123-123(1)
Authors: Farhi J.; Ginat S.; Weissman A.; Nahum H.; Glezerman M.; Levran D.

Extended culture of excess embryos after day 3 embryo transfer (ET) as a pregnancy predictor
pp. 123-123(1)
Authors: Kiltz R.J.; Polanski V.; Woodhouse D.J.; Miller D.B.

Race and assisted reproduction: A case-controlled study of outcomes in African-American and Caucasian women
pp. 123-123(1)
Authors: James C.E.; Hammond K.R.; Steinkampf M.P.

Application of ginkgo biloba in assisted reproduction therapy
pp. 124-124(1)
Authors: Paulus W.E.; Zhang M.; Strehler E.; Reeka N.; Sterzik K.

Biologic effect of leuprolide acetate on luteinizing hormone (LH) in human reproduction
pp. 124-124(1)
Authors: Vega-Cardenas J.; Hernandez-Ayup S.; Galache-Vega P.; Santos-Haliscak R.; Batiza-Resendiz V.A.; Garza S.

Highly purified human menopausal gonadotropin (hMG-HP; Menopur(R)) versus purified urinary follicle stimulating hormone (Po-FSH; Ovitrop(R)) for the induction of superovulation in women undergoing assisted reproductive techniques
pp. 124-124(1)
Authors: Allahbadia G.N.; Gandhi G.N.; Merchant R.M.; Kadam K.S.; Virk S.P.S.H.; Kaur K.M.

The correlation between follicular fluid inhibin B and embryo development
pp. 125-125(1)
Authors: Wang H.-S.; Chang C.-L.; Soong Y.-K.

Defining poor responders-The relationship between the number of oocytes retrieved and the pregnancy rate in IVF and ICSI
pp. 125-125(1)
Authors: Sallam H.N.; Agameya A.-F.; Sallam A.N.; Ezzeldin F.; Rahman A.F.

Mitochondrial ATPase 6 gene expression in mouse oocytes matured in vitro after vitrification at the germinal vesicle stage
pp. 125-125(1)
Authors: Eun P.S.; Hwan L.S.; Jin J.H.; Jae K.J.; Ki Y.T.; Yul C.K.

Histologic evaluation of fresh human ovarian tissue prior to cryopreservation
pp. 125-126(2)
Authors: Azem F.; Ben-Yosef D.; Kossoy N.; Cohen T.; Amit A.; Lessing J.

Functional analysis of oligospermic samples following ultra-rapid freezing using cryoloops
pp. 126-126(1)
Authors: Schuster T.G.; Keller L.M.; Ohl D.A.; Smith G.D.

Successful frozen embryo transfer following subsequent freeze-thaw cycles
pp. 126-126(1)
Authors: Langley M.; Marek D.; Nackley A.; Doody K.; Doody K.

How many frozen embryos should be transferred: Is 3 better than 2?
pp. 126-127(2)
Authors: Hazlett W.; Karande V.; Vietzke M.

Assisted hatching and cryopreservation: Impact on pregnancy rates in frozen embryo transfers
pp. 127-127(1)
Authors: Johnson E.; Caswell W.; Tucker M.; SanRoman G.; Cain K.; Stelling J.

Blastomere survival during cryopreservation is directly related to pregnancy rate following FET
pp. 127-127(1)
Authors: Kovacs P.; Pal L.; Witt B.R.; Barad D.H.

Are elevated estradiol levels detrimental to embryonic development?
pp. 127-128(2)
Authors: Spandorfer S.D.; Bodine R.; Clarke R.; Veeck L.; Rosenwaks Z.

Post thawing culture conditions affecting cleavage and implantation of cryopreserved embryos
pp. 128-128(1)
Author: Stein A.

Non-homogeneous hyperechogenic pattern three days after frozen embryo transfer is associated with lower pregnancy rates
pp. 128-128(1)
Authors: Check J.H.; Dietterich C.; Nazari A.; Lurie D.; Choe J.K.; Check M.L.

Preliminary experience in ovocytes cryopreservation
pp. 128-129(2)
Authors: Albani E.; Morreale G.; Parini V.; Baggiani A.; Colombo G.V.; Setti P.E.L.

Successful cryopreservation of human spermatozoa by direct plunging into liquid nitrogen (vitrification) without cryoprotectants
pp. 129-129(1)
Authors: Nawroth F.; Isachenko V.; Dessole S.; Isachenko E.

Increased sucrose concentration enhances cryopreserved human ovarian tissue morphological features
pp. 129-129(1)
Authors: Marsella T.; Xella S.; Gallinelli A.; Tagliasacchi D.; Giulini S.; Volpe A.

Ultra-rapid freezing of severe oligospermic samples using cryoloops
pp. 129-130(2)
Authors: Keller L.M.; Schuster T.G.; Ohl D.A.; Smith G.D.

Cryopreservation of mouse and human cleavage stage embryos by slow freezing with ethylene glycol (EG) and 1,2-propanediol (PROH)
pp. 130-130(1)
Authors: Hyung K.T.; Kyung C.S.; Thomas K.; Jae K.J.; Wook H.S.; Yul C.K.

Embryo cryopreservation: a two-year experience with three programmable cryopreservation units
pp. 130-130(1)
Authors: Behr B.; Tan T.; Khoury C.; Le A.; Ivakhnenko V.; Tran C.

Progesterone level on the day of HCG injection adversely affects blastomere survival during cryopreservation
pp. 130-131(2)
Authors: Kovacs P.; Pal L.; Barad D.H.

The cumulative chance for a liveborn delivery following elective pronuclear stage cryopreservation in patients with high response cycles
pp. 131-131(1)
Authors: Contag S.; Thornhill A.; Tummon I.; Damario M.

Improved pregnancy rates from cryopreserved embryos through earlier embryo transfer
pp. 131-132(2)
Authors: Weckstein L.N.; Jacobson A.; Willman S.; Smikle C.; Walker D.; Ivani K.

Success in assisted reproduction cycles with frozen sperm is not affected by the time that it has been cryopreserved
pp. 132-132(1)
Authors: Garrido N.; Meseguer M.; Remohi J.; Simon C.; Pellicer A.

Frozen embryo transfer of single blastocysts
pp. 132-132(1)
Authors: Marek D.; Langley M.; Nackley A.C.; Doody K.M.; Doody K.J.

Ovarian tissue cryopreservation prior to cancer treatment: The Lis experience
pp. 132-133(2)
Authors: Azem F.; Ben-Yosef D.; Cohen T.; Kapustiansky R.; Amit A.; Lessing J.

Successful high pregnancy rate after vitrification of human blastocysts using a cryoloop
pp. 133-133(1)
Authors: Fukunaga N.; Kyono K.; Haigo K.; Chiba S.; Nakajo Y.; Fuchinoue K.

Microsort^tm babies: 1994-2002 preliminary postnatal follow-up results
pp. 133-133(1)
Authors: Stern H.; Wiley S.; Matken R.; Karabinus D.; Blauer K.L.

Growth and production of hCG by trophoblast cells is similar in vitro and in vivo
pp. 133-134(2)
Authors: Mendelsohn F.A.; Arcuri D.; Bergh P.; Sandler B.; Grunfeld L.; Copperman A.B.

Hatching of human blastocysts in vitro on day 6 of embryo culture is correlated with increased pregnancy, implantation and live birth rates in human IVF-ET
pp. 134-134(1)
Authors: Smith L.K.; Roots E.H.; Dorsett M.J.O.

Effect of suppressed early- and late-follicular phase LH serum levels in assisted reproduction
pp. 134-134(1)
Authors: Cabrera R.A.; Wong B.C.; Williams S.C.; Mayer J.F.; Gibbons W.E.; Oehninger S.

Cumulative delivery rate after three consecutive in vitro fertilization (IVF) cycles-implications for diagnosis of immunologic infertility
pp. 134-135(2)
Author: Stassart J.P.

Maximal historical FSH is a better predictor of cycle outcome than the baseline FSH for the IVF cycle
pp. 135-135(1)
Authors: Pal L.; Witt B.R.

Presence of eight-cell embryos is a positive indicator for cycle outcome in patients 40 years of age and older following an IVF treatment cycle
pp. 135-135(1)
Authors: Johnson E.; VerMilyea M.; Caswell W.; Cain K.; Roman G.S.

Predictive value of sperm morphology (strict criteria) on intrauterine insemination pregnancy outcomes
pp. 135-136(2)
Authors: Kort H.I.; Davis A.L.; Elsner C.W.; Massey J.B.; Shapiro D.B.; Roudebush W.E.

Graduated embryo score (GES) is superior to day-3 morphologic criteria alone for predicting ART outcome
pp. 136-136(1)
Authors: Fisch J.D.; Sher G.; Rodriguez H.; Overby G.; Adamowicz M.; Keskintepe L.

Optimizing pregnancy outcome in an oocyte donation program
pp. 136-136(1)
Authors: Mirkin S.; Gimeno T.G.; Bovea C.; Mayer J.F.; Stadtmauer L.A.; Oehninger S.C.

Day 3 embryo-assessment criteria validity for blastocyst transfer in oocyte donation using a co-culture program
pp. 136-137(2)
Authors: Rossal L.P.; Bosch E.; Escudero E.; Remohi J.; Pellicer A.; Simon C.

Use of the GnRH antagonist antagon^tm for a poor prognosis in-vitro fertilization (IVF) population results in low pregnancy and implantation rates
pp. 137-137(1)
Authors: Shapiro D.; Toledo A.; Carter M.; Wininger D.; Wright G.

7 year descriptive summary of ectopic pregnancies occurring after fresh and frozen IVF cycles
pp. 137-137(1)
Authors: Kashyap S.; Chung P.; Kligman I.; Rosenwaks Z.

The quality of inner cell mass (ICM) correlates with clinical spontaneous abortion (SAB)
pp. 137-138(2)
Authors: Wun W.-S.A.; Grunert G.M.; Dunn R.; Valdes C.; Schenk L.; Mangal R.

Blastocyst versus day-3 embryo transfers: A comparison of fresh and thaw cycle cumulative outcomes
pp. 138-138(1)
Authors: Zimon A.E.; Witmyer J.; Reindollar R.H.

Autologous endometrial coculture (AECC) in patients with IVF failure: correlations of outcome with epidermal growth factor (EGF) and transforming growth factor-2 (TGF-2)
pp. 138-139(2)
Authors: Chen D.; Spandorfer S.D.; Pascal P.M.; Veeck L.L.; Witkin S.S.; Rosenwaks Z.

Day 6 blastocyst transfers increase the pregnancy, implantation and live birth rates compared to day 5 blastocyst transfers in human IVF-ET
pp. 139-139(1)
Authors: Smith L.K.; Roots E.H.; Dorsett M.J.O.

Factors affecting the outcome of pregnancy following multifetal pregnancy reduction
pp. 139-139(1)
Authors: Kang I.S.; Kim H.O.; Song J.H.; Song I.O.; Jun J.Y.; Koong M.K.

Pregnancy outcome and neonatal data on children born after ICSI with testicular sperm in obstructive and non-obstructive azoospermia
pp. 139-140(2)
Authors: Vernaeve V.; Bonduelle M.; Tournaye H.; Camus M.; Van Steirteghem A.; Devroey P.

Mathematical model predicts day 6 transfer outcomes
pp. 140-140(1)
Authors: Trimarchi J.R.; Hackett R.J.; Pierce D.J.; Keefe D.L.

Can initial BHCG level predict a multiple ART pregnancy?
pp. 140-140(1)
Authors: Ouhilal S.; Pollack S.E.; Witt B.R.; Rimstidt K.; Santoro N.

Fresh embryo transfer (ET) pregnancy rates are not compromised by freezing portion of embryos at 2 pronuclear (2PN) stage
pp. 140-141(2)
Authors: Shen S.; Wong C.; Ho K.; Telles T.L.; Fujimoto V.Y.; Cedars M.I.

Delivery rates in poor responders that decline cycle cancellation
pp. 141-141(1)
Authors: Cochran R.A.; Jutras M.L.; Jutras M.T.

Is ultrasound guidance or length of time to accomplish embryo transfer more important in achieving pregnancy in first cycle in vitro fertilization (IVF) patients?
pp. 141-141(1)
Authors: McCulloch S.B.; Sullivan K.; Sopelak V.M.; Hines R.S.

Obstetric and perinatal risks in IVF pregnancies conceived with own oocytes or donor oocytes
pp. 141-142(2)
Authors: Gaytan J.; Troncoso C.; Rossal L.P.; Bosch E.; Pellicer A.; Remohi J.

Impact on embryo quality when adding LH (hMG) in microdose lupron stimulation of low responders
pp. 142-142(1)
Authors: Mangan P.; Hazlett D.; Karande V.; Vietzke M.; Nasta T.

A comparison of the effects of short-term oocyte culture in glucose/phosphate-free medium or in glucose/phosphate-supplemented medium prior to intracytoplasmic sperm injection (ICSI) on clinical outcome
pp. 142-143(2)
Authors: Stoddart N.R.; Rho H.C.; Hussain A.; Fleming S.D.; Bernhisel M.A.

Media comparison: in vitro care and irvine scientific
pp. 143-143(1)
Authors: Hazlett W.; Karande V.; Jobanputra K.; Vietzke M.

Outcome of intracytoplasmic sperm injection (ICSI) using epididymal and testicular sperm from azoospermic men: the cleveland clinic experience
pp. 143-143(1)
Authors: Oder M.; Saleh R.A.; Kattal N.; Bedaiwy M.A.; Thomas A.J.; Agarwal A.

Gestational surrogacy: A model to study the maximum success rates offered by an IVF program
pp. 143-144(2)
Authors: Lalwani S.I.; Berger M.; Klipstein S.; Timmreck L.; Gardella J.; Reindollar R.

Do hydrosalpinges affect IVF outcome?
pp. 144-144(1)
Authors: Noyes N.; Jones K.; Patel A.; Kwiakowski A.; Ryan C.; Krey L.C.

Tenaculum and local anesthetic use for embryo transfer (ET) does not compromise pregnancy rates in fresh in vitro fertilization (IVF) cycles and embryo thaw and transfer (ET-T) cycles
pp. 144-144(1)
Authors: Strawn E.Y.; Tucker A.; Roesler M.; Granlund A.; Gunnarson C.; Eastwood D.

Progress we can be proud of: US trends in assisted reproduction over its first 20 years
pp. 144-145(2)
Author: Toner J.P.

Biochemical pregnancy: Clinical significance in assisted reproduction
pp. 145-145(1)
Authors: Serra V.S.; Vidal C.; Bellver J.; Crespo J.; Remohi J.; Pellicer A.

Determination of progesterone levels on day of hCG will predict IVF pregnancy outcomes
pp. 145-145(1)
Authors: Shapiro D.B.; Wininger J.D.; Fisher A.M.; Combs B.F.; Durrance M.H.; Roudebush W.E.

Oocyte and embryo quality in IVF cycles with GnRH antagonist vs GnRH agonist
pp. 145-146(2)
Authors: Bosch E.; Albert C.; Ruiz A.; Simon C.; Remohi J.; Pellicer A.

Possible human chimera detected prenatally after in vitro fertilization: A case report
pp. 146-146(1)
Authors: Plachot M.; Simon-Bouy B.; Mokdad A.; Lavaud N.; Muti C.; Bazin A.

Evaluation of the outcome of assisted reproductive techniques in patients with inflammatory bowel disease: A cross sectional study
pp. 146-146(1)
Authors: Bedaiwy M.A.; Miller K.; Goldberg J.M.; Attaran M.; Agarwal A.; Falcone T.

Microflare versus coflare stimulation outcome in in-vitro fertilization (IVF)
pp. 146-147(2)
Authors: Chen D.; Schattman G.L.; Spandorfer S.D.; Yih M.C.; Veeck L.L.; Rosenwaks Z.

Finding the ideal number of embryos to transfer on day 3 of development when there is a good embryo cohort?
pp. 147-147(1)
Authors: Troncoso C.; Escudero E.; Gaytan J.; Remohi J.; Pellicer A.; Simon C.

Singleton pregnancy resulting from recombinant versus urinary human chorionic gonadotropin-a meta-analysis
pp. 147-148(2)
Authors: Daya S.; Gunby J.

Comparison of intracytoplasmic sperm injection pregnancy rates in Eastern Indian and Caucasian women
pp. 148-148(1)
Authors: Smikle C.; Willman S.P.; Walker D.; Ivani K.

Progesterone elevation during GnRH antagonists cycles in IVF adversely affects pregnancy and implantation rates
pp. 148-148(1)
Authors: Valencia I.; Bosch E.; Simon C.; Troncoso C.; Remohi J.; Pellicer A.

Oocyte recruitment in IVF patients with limited ovarian reserve (LOR), maximizing quality of ooctyes and embryos
pp. 148-149(2)
Authors: Daly D.C.; Daly C.L.; Mayo D.; Jacobs A.

An oral contraceptive (OCP) microdose flare leuprolide acetate (LA) stimulation protocol is useful for poor prognosis patients undergoing in vitro fertilization (IVF)
pp. 149-149(1)
Authors: Sanghvi A.; Noyes N.; Krey L.C.

Polycystic ovarian syndrome (PCOS) patients have a favorable response to ganirelix acetate during controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF)-embryo transfer (ET)
pp. 149-150(2)
Authors: Bracero N.; Jurema M.; Vlahos N.; Kolp L.; Garcia J.

GnRH antagonists and poor responders: is there hope after a failed microdose agonist flare cycle?
pp. 150-150(1)
Authors: Chen S.H.; Mack C.K.; Cekleniak N.A.; Garrisi M.G.; Schramm A.T.; Sable D.B.

An embryonic perspective of a comparative randomized study of Lupron/Follistim versus Follistim/Antagon in IVF
pp. 150-150(1)
Authors: Batzofin J.; Feinman M.; Kolb B.; Nelson J.; Wilcox J.; Norbryhn G.

Absence of improvement by daily low-dose aspirin in ovarian stimulation during ART cycles
pp. 150-151(2)
Authors: Kohl-Thomas B.M.; Wincek T.J.; Pliego J.F.; Spiekerman M.; Arizola D.; Kuehl T.J.

Are additional hMG necessary with GnRH antagonists in IVF/ICSI?
pp. 151-151(1)
Authors: Rongieres C.; Meistermann D.; Moreau L.; Wittemer C.; Ohl J.; Nisand I.

Use of gonadotropin releasing hormone (GnRH) antagonist vs agonist in repeat stimulation cycles of poor responders
pp. 151-151(1)
Authors: Jindal S.K.; Gatzen C.; Barad D.

Is endometrial thickness, assessed on the day of HCG administration, predictive of ongoing pregnancy in patients undergoing intrauterine insemination after ovarian stimulation with clomiphene citrate?
pp. 151-152(2)
Authors: Kolibianakis E.M.; Fatemi H.M.; Osmanagaoglu K.; Evenepoel J.; Steirteghem A.V.; Devroey P.

The effect of different stimulation regimens on outcomes in IVF/ICSI for poor responders to ovarian stimulation
pp. 152-152(1)
Authors: Sajjad Y.; Wood S.; Thomas K.; Sephton V.; Jones I.; Troup S.

Natural cycle in poor responders
pp. 152-152(1)
Authors: Ballesteros A.; Landeras J.; Sagastegui C.G.; Molla M.; Perez-Cano I.; Remohi J.

The effects of a six-week aerobic and weight-resistance training program on infertility patients diagnosed with polycystic ovary syndrome
pp. 152-153(2)
Author: Talluto C.C.

Adverse effects of hydrosalpinx epithelial cell culture conditioned medium from Chinese infertile women on sperm motility and acrosome reaction
pp. 153-153(1)
Authors: Ajonuma L.C.; Ng E.H.-Y.; Briton-Jones C.; Lok I.H.; Haines C.J.; Chan H.C.

Effects of co-administration of metformin and clomiphine citrate (CC) on hormonal profile and pregnancy rates in non-obese patients with polycystic ovary syndrome (PCOS): results of a clinical trial
pp. 153-153(1)
Authors: Singh I.; Saleh R.A.; Kattal N.; Hatwal A.; Sarkar S.; Agarwal A.

Clomiphene and intrauterine insemination (IUI)-what is the best way to time insemination?
pp. 154-154(1)
Authors: Lewis V.; Guzick D.S.

Induction of ovulation and ovarian cancer: A meta-analysis
pp. 154-154(1)
Authors: Kashyap S.; Moher D.; Fung M.F.K.

Tissue sampling technique affects accuracy of karyotype from missed abortions
pp. 154-155(2)
Authors: Lathi R.B.; Milki A.A.

Fertility and pregnancy outcome following hypogastric artery ligation for severe post-partum hemorrhage
pp. 155-155(1)
Authors: Nizard J.; Barinque L.; Frydman R.; Fernandez H.

Pregnancy outcome, once viability is ascertained, is not associated with endometrial thickness on day of hCG in patients with polycystic ovarian syndrome (PCOS) or other infertility diagnoses undergoing controlled ovarian hyperstimulation (COH)
pp. 155-155(1)
Authors: Feigenbaum S.; Mukul L.; Kelsey S.; Lovell N.; Zinn N.; Edmunds D.

Anthropometric variation in ovulatory and anovulatory infertility
pp. 155-156(2)
Authors: Potdar N.; Ojidu J.; Odukoya O.A.

Prevalence, presentation and management of ovarian pregnancies-A comparison between two decades
pp. 156-156(1)
Authors: Raziel A.; Mordechai E.; Friedler S.; Schachter M.; Panski M.; Ron-El R.

Study on early prediction of ovarian hyperstimulation syndrome during hMG-hCG treatment using a damped oscillation rheometer
pp. 156-156(1)
Authors: Aisaka K.; Doi M.; Obata S.; Watanabe T.; Ooka F.; Kaibara M.

Intramural leiomyomata which enlarge during controlled ovarian hyperstimulation (COH) for IVF have individual characteristics
pp. 156-157(2)
Authors: Zeyneloglu H.B.; Ozdemir B.H.; Haydardedeoglu B.; Batioglu S.A.

External validation of a prognostic model for the detection of functional follicular cyst and the risk of ovarian cancer in anechoic ovarian tumors: a European multicenter study
pp. 157-157(1)
Authors: Guerriero S.; Ajossa S.; Alcazar J.L.; Coccia M.E.; Gerada M.; Melis G.B.

Colpohydrosonography (CHS) more accurately measures uterine cavity depth than conventional ultrasound
pp. 157-157(1)
Authors: Fisch J.D.; Sher G.

A blind embryo transfer is a rate limiting step to successful IVF
pp. 157-158(2)
Authors: Allahbadia G.; Gandhi G.; Athavale U.; Merchant R.; Virk S.P.S.; Kaur K.

Case report. role of saline infusion sonohysterography (SIS) in the diagnosis of abnormal uterine bleeding (AUB) in a patient with uterine diverticulum
pp. 158-158(1)
Authors: Pinto A.B.M.; Siegel C.L.; Weber S.B.; Odem R.R.; Ratts V.S.

Pregnancy outcomes after fallopian tube recanalization (FTR): oil-based vs. water-soluble contrast agents
pp. 158-158(1)
Authors: Pinto A.B.M.; Hovsepian D.M.; Wattanakumtornkul S.; Pilgram T.K.

Rapid reaccumulation of hydrometra at embryo transfer in patients with hydrosalpinx drained at oocyte retrieval
pp. 158-159(2)
Authors: Hinckley M.D.; Milki A.A.

Phase I study of topical testosterone in estradiol- and testosterone-deficient postmenopausal women
pp. 159-159(1)
Authors: Wright C.; Heuer M.; Brisker J.; Muenz L.; Boxenbaum H.

Efficacy and safety study of a new synthetic 10-component, modified release conjugated estrogens (CE) tablet for treatment of vasomotor symptoms in postmenopausal women
pp. 159-159(1)
Authors: Utian W.H.; Leonard T.W.; Davis A.D.; Vega R.Y.

Characterization of inactive components in conjugated equine estrogens
pp. 159-159(1)
Authors: Leonard T.W.; Whittle R.R.; Hill E.N.; Ponder G.W.

Effect of Tibolone and its metabolites on vascular endothelial growth factor (VEGF) isoforms 121 and 165 in ishikawa cells
pp. 159-160(2)
Authors: Mirkin S.; Leslie S.; Billeter M.; Mahony M.C.; Archer D.F.

Pacemaker cells of the urethra: A new discovery and the impact of age
pp. 160-160(1)
Authors: Ali A.F.M.; El-Shayeb S.

Associations of reproductive hormones with transition to menopause in women age 35-47
pp. 160-160(1)
Authors: Sammel M.D.; Martin P.G.; Freeman E.W.

Uterine endometrial stability is dependent on the presence of both estrogen and progesterone
pp. 160-161(2)
Authors: Eisenberg E.; Bruner-Tran K.; Keller N.; Hargrove J.T.; Osteen K.G.

Micellar nanoparticles: a new topical emulsion for systemic delivery of estradiol and testosterone
pp. 161-161(1)
Authors: Heuer M.; Wright C.

Considering heterogeneity in a power analysis exemplified by ovarian aging
pp. 161-161(1)
Authors: Asselt K.v.; Kok H.; Pearson P.; Velde E.t.; Grobbee D.; Sandkuijl L.

Identification and functional characterization of disease-associated genes in premature ovarian failure
pp. 161-162(2)
Authors: Schroer A.; Kupker W.; Diedrich K.

Transvaginal ultrasound assessment of the endometrium of postmenopausal women before using hormone replacement therapy
pp. 162-162(1)
Authors: Santiago R.; Romaguera J.

Clinical response as an endpoint in studies of estrogen replacement therapy in postmenopausal women
pp. 162-162(1)
Authors: Simon J.A.; Heuer M.

hMG given subcutaneously may be associated with serum sickness-like reactions
pp. 162-162(1)
Authors: Thoma S.; Hudelson J.; Guth B.; Thomas S.; Gentry W.L.

Nursing perspective of a comparative randomized study of Lupron/Follistim versus Follistim/Antagon in IVF
pp. 163-163(1)
Authors: Norbryhn G.A.; Feinman M.; Kolb B.; Nelson J.; Wilcox J.; Batzofin J.

Annulate lamellae assembly in non-inseminated and failed fertilized human oocytes
pp. 163-163(1)
Authors: Rawe V.Y.; Olmedo S.B.; Nodar F.N.; Ponzio R.; Sutovsky P.

Estrogen receptors alpha are present in human ovarian cells
pp. 163-164(2)
Authors: Economou L.; Papamitsou T.; Papaioannidou P.G.; Manthos A.; Alvanou A.; Miliaras D.

Egr-1 inhibits the induction of 17-HSD type 2 gene by Sp1 or Sp3 in human endometrial epithelial cells
pp. 164-164(1)
Authors: Yang S.; Fang Z.; Dogan H.; Tamura M.; Gurates B.; Bulun S.

Abnormal mitochondrial structure and decreased mitochondrial DNA expression in human unfertilized oocytes and arrested embryos
pp. 164-164(1)
Authors: Hsieh R.-H.; Au H.-K.; Tsai N.-M.; Li J.-W.; Tzeng C.-R.

Non-invasive imaging of spindle dynamics during physiologic and pharmacologic mammalian oocyte activation
pp. 164-165(2)
Authors: Navarro P.A.A.S.; Liu L.; Trimarchi J.R.; Ferriani R.A.; Keefe D.L.

Serine/threonine kinases in the three related mitogen activated protein kinase (MAPK) families have novel cytoplasmic-nuclear dynamics in preimplantation mouse embryos and trophoblast stem cells (TSC)
pp. 165-165(1)
Authors: Puscheck E.; Wang Y.; Wygle D.; Barisic D.; Trostinskaya A.; Rappolee D.

Adenosine triphosphate induces activation of caspase in apoptosis of human granulosa-luteal cells
pp. 165-165(1)
Authors: Tai C.-J.; Chang S.-J.; Leung P.C.K.; Tzeng C.-R.

Differential gene expression between the luminal epithelium of the implantation and interimplantation sites
pp. 165-166(2)
Authors: Yoon S.-J.; Park C.-E.; Ko J.-J.; Yoon T.-K.; Cha K.-Y.; Lee K.-A.

The entire mitogen activated protein kinase (MAPK) pathway is present in preimplantation mouse embryos and trophoblast stem cells (TSC)
pp. 166-166(1)
Authors: Puscheck E.; Wang F.; Sun T.; Barisic D.; Trostinskaya A.; Rappolee D.

Increased sperm DNA damage in partners of women with unexplained recurrent miscarriages: preliminary report
pp. 166-166(1)
Authors: Tomsu M.; Pacey A.A.; Li T.C.; Ledger W.L.

Arsenite induces aberrations in meiosis that can be rescued by co-administration of N-acetylcysteine in mouse
pp. 166-166(1)
Authors: Navarro P.A.A.S.; Liu L.; Ferriani R.A.; Keefe D.L.

Apoptosis in maternal-fetal interface may affect the fetal survival during early pregnancy
pp. 166-167(2)
Authors: Lee J.-A.; Lee K.-H.; Baek K.-H.; Jun Y.-S.; Choi B.-C.; Kim J.-W.

Levels of seminal reactive oxygen species (ROS) are highly correlated with apoptosis in ejaculated spermatozoa from infertile men
pp. 167-167(1)
Authors: Moustafa M.H.; Saleh R.A.; Oder M.; Sharma R.K.; Abdel-Hafez M.A.; Agarwal A.

MAPK regulate MMP-9 gene expression induced by IL-1 and TNF- in cytotrophoblastic cells
pp. 167-167(1)
Authors: Chen S.; Zhang X.; Pang Z.; Xing F.

Expression of PTEN in human endometrium throughout the menstrual cycle and during early pregnancy and its regulation by progesterone
pp. 168-168(1)
Authors: Kayisli U.A.; Guzelolgu-Kayisli O.; Berkkanoglu M.; Arici A.

Nicotine and the fertilization story: smoking versus endogenous function
pp. 168-168(1)
Authors: Burkman L.J.; Bodziak M.; Gurunatha R.; Palaszewski D.; Mroz R.

Fetal erythroblastosis as an impending sign of abortion
pp. 168-169(2)
Authors: Ali A.F.M.; Khalil I.; Shaker S.; Hamed W.M.

Histological evaluation and in situ localization of apoptosis in fresh and cryopreserved ovarian tissue
pp. 169-169(1)
Authors: Bedaiwy M.A.; Hussein M.R.; Jeremias E.; Sharma R.K.; Agarwal A.; Falcone T.

Prostacyclin enhances embryo hatching
pp. 169-169(1)
Authors: Huang J.-C.; Wun W.-S.A.; Goldsby J.S.; Matijevic-Aleksic N.; Wu K.K.

Analysis of the WNT-4 gene in women with congenital absence of the uterus and vagina
pp. 169-170(2)
Authors: Wu H.-H.; Reindollar R.H.; Gray M.R.

Granulocyte macrophage colony stimulating factor (GM-CSF) stimulates mouse blastocyst ICM development only when culture conditions are suboptimal
pp. 170-170(1)
Authors: Karagenc L.; Lane M.; Gardner D.K.

Production of a healthy calf after transfer of the embryo originated from rejuvenated defective oocytes from age-related infertile cattle by germinal vesicle transfer
pp. 170-170(1)
Author: Kuwayama M.

Uterine leiomyomas are characterized by abnormal expression of Wnt signaling proteins and disordered collagen deposition
pp. 170-170(1)
Authors: Prupas C.S.; Mayers C.M.; Tsibris J.C.M.; Segars J.H.; Leppert P.C.

Fas-Fas ligand system regulates invasiveness of trophoblast in first trimester pregnancy
pp. 171-171(1)
Authors: Sbracia M.; Scarpellini F.; Rossi G.; Poverini R.

Practice patterns in vasectomy reversal surgery: results of a questionnaire study among practicing urologists
pp. 171-171(1)
Authors: Crain D.S.; Roberts J.L.; Amling C.L.

Arteriovenous aberration as a cause of idiopathic repeated fetal wastage and its treatment by laparoscopic intrauterine injection of interferon 2
pp. 171-171(1)
Authors: Ali A.F.M.; NasrEldin M.H.; Hamed W.M.; Anwar I.

Long-term fertility prognosis following selective salpingography and tubal catheterization in women with proximal tubal blockage
pp. 171-172(2)
Authors: Papaioannou S.; Afanan M.; Olufowobi O.O.; Girling A.; Ola B.; Sharif K.

Severe evaporation by warmed only gas causes hypothermia and is prevented by warmed wet gas
pp. 172-172(1)
Authors: Ott D.; Johnston G.

Aspiration of the gestational sac as an alternative to dilation and curettage following a missed abortion
pp. 172-172(1)
Authors: Fakih M.H.; Grossman M.P.

Laparoscopic intratubal bee venom in the treatment of proximal tubal obstruction: a new modality
pp. 172-173(2)
Authors: Ali A.F.M.; Mostafa M.; Hamed W.M.; AbdelRahman A.E.

Peritoneal drying and desiccation is caused by heated only carbon dioxide
pp. 173-173(1)
Authors: Ott D.; Johnston G.

GnRH-antagonists: useful adjuncts for stimulation in women with poor ovarian reserve
pp. 173-173(1)
Authors: Noyes N.; Krey L.C.

Follicular serum androgen profiles differ when GnRH agonists and antagonists are used
pp. 173-174(2)
Authors: Chung K.; Krey L.; Ambrosini G.; Katz J.; Noyes N.

Role of FSH hormone gene (FSRH) mutations in young poor responders undergoing ART
pp. 174-174(1)
Authors: Taskin O.; Ozcan M.; Simsek M.; Alpek O.; Luleci G.; Kursun S.

Pituitary-ovarian recovery after oral contraceptive use before in vitro fertilization (IVF)
pp. 174-174(1)
Authors: Dickey R.P.; Pyrzak R.; Lu P.Y.; Sartor B.M.; Taylor S.N.; Storment J.M.

Combined use of GnRH analog and antagonist: redundancy vs. complementary action
pp. 174-175(2)
Authors: Goldstein D.B.; Bedernicianu F.; Zhang J.; Bulavina M.; Voicu M.; Fong H.

Pregnancy rates are maintained in poor responders with a simple GnRH antagonist protocol compared to microdose GnRH agonist flare
pp. 175-175(1)
Authors: Hurst B.S.; Matthews M.M.; Papadakis M.A.; Marshburn P.B.

Fine adjustments for a fixed dose of rec-hFSH, avoid ovarian hyperstimulation and high order multiple pregnancy without compromising pregnancy rates in anovulatory patients
pp. 175-175(1)
Authors: Berta C.L.; Ayup S.H.

ICSI with minimal ovarian stimulation and follicular monitorization
pp. 175-176(2)
Authors: Pereyra-Quinones R.; Montemayor-Garza R.; Arenas-Montezco M.L.; Santos-Haliscak R.; Galache-Vega P.; Hernandez-Ayup S.

Pregnancy in high FSH: a new modality of treatment
pp. 176-176(1)
Authors: Ali A.F.M.; Rafik M.; Mostafa M.; Hamed W.M.

A pilot study to assess oral contraceptive (OC) pretreatment in women undergoing controlled ovarian hyperstimulation (COH) in ganirelix acetate cycles
pp. 176-176(1)
Authors: Meldrum D.; Scott R.; Levy M.J.; Alper M.; Noyes N.

Single dose gonadotropin releasing hormone (GnRH) antagonist cetrotide^tm is effective in luteinizing hormone (LH) surge suppression for in vitro fertilization (IVF)
pp. 176-177(2)
Authors: Piquette G.N.; Picciano P.; Konialian J.

Controlled ovarian stimulation using GnRH antagonist cetrorelix single dose protocol: a comparative study with GnRH agonist treatment
pp. 177-177(1)
Authors: Olivennes F.J.; Samama M.; Kadoch I.J.; Fanchin R.; Righini C.; Frydman R.

Is a day 5 step-down, step-up, or continue on protocol predictive of success in first cycle in vitro fertilization (IVF) patients?
pp. 177-177(1)
Authors: McCulloch S.B.; Sullivan K.; Sopelak V.M.; Hines R.S.

Use of GnRH antagonist for ovarian stimulation in PCOS patients undergoing IVF/ICSI is associated with less total injections and comparable clinical outcome
pp. 178-178(1)
Authors: Abae M.; Firisin W.K.; Lopez K.; Rodriguez H.F.

Improvement of ovarian stimulation protocols and preparation of endometrium is necessary to increase pregnancy rate in oocyte recipient patients
pp. 178-178(1)
Authors: Ballesteros A.; Landeras J.; Perez-Cano I.; Gomez E.; Amorocho B.; Cano F.

A prospective study to evaluate whether gonadotropin releasing hormone (GnRH) antagonists have an adverse effect on embryo implantation
pp. 178-178(1)
Authors: Check J.H.; Choe J.K.; Nazari A.; Davies E.; Kiefer D.

GnRH antagonist in poor responder patients undergoing an ART
pp. 179-179(1)
Authors: Borini A.; Trevisi M.R.; Pattuelli M.; Iadarola I.; Cattoli M.; Flamigni C.

GnRH flare improves pregnancy rates only in a subset of poor responders
pp. 179-179(1)
Authors: Confino E.; Zhang X.; Kazer R.

Prion transmission in blood and urine: What are the implications for recombinant and urinary-derived gonadotrophins?
pp. 179-179(1)
Author: Reichl H.

GnRH antagonists: improvement in clinical results needs a training period
pp. 179-180(2)
Authors: Rongieres C.; Meistermann D.; Viville S.; Moreau L.; Bettahar K.; Nisand I.

DNA microarray analysis in down syndrome
pp. 180-180(1)
Authors: Jung I.H.; Lee S.M.; Lee S.H.; Park J.H.; Cha K.Y.; Lee K.W.

Conservative preimplantation genetic diagnosis (CPGD)
pp. 180-180(1)
Authors: Schmutzler A.G.; Chen W.; Weimer J.; Mettler L.; Jonat W.; Arnold N.

In vitro development of human triploid zygotes reconstructed by pronuclear transfer
pp. 180-181(2)
Authors: Zhang J.; Shu Y.M.; Krey L.C.; Liu H.; Zhuang G.L.; Grifo J.

Advancing maternal age compromises control of cell cycle checkpoint for aneuploidies in human embryos cultured in vitro
pp. 181-181(1)
Authors: Asakura H.; Katayama K.P.; Stehlik E.F.; Stehlik J.C.; Winchester-Peden K.

A randomized controlled study to evaluate the effect of laser assisted hatching on human embryo development
pp. 181-181(1)
Authors: Wong B.C.; Boyd C.A.; Lanzendorf S.E.

The effect of different embryo biopsy procedures for PGD on blastocyst formation and pregnancy
pp. 181-182(2)
Authors: Balaban B.; Isiklar A.; Urman B.

Reactive oxygen species: a biological marker for early embryonic development in intracytoplasmic sperm injection (ICSI) cycles
pp. 182-182(1)
Authors: Bedaiwy M.A.; Falcone T.; Miller K.; Abdel-Aleem A.; Al-Hussaini T.; Agarwal A.

Detection of chromosomal aberrations by preimplantation genetic diagnosis (PGD)
pp. 182-182(1)
Authors: Cheung S.W.; Wun W.S.; Angus S.C.; Cooper M.L.; Ybarra A.A.; Grunert G.M.

The effect of embryo morphology on inner cell mass isolation and production of human embryonic stem cell lines
pp. 182-183(2)
Authors: Lanzendorf S.E.; Boyd C.A.; Wright D.L.

Three round FISH aneuploidy screening test for 12 chromosomes using human blastomeres
pp. 183-183(1)
Authors: Li M.; Drury K.C.; Kovalinskaia L.; Williams R.S.

Blastocyst transfer after preimplantation genetic diagnosis
pp. 183-184(2)
Authors: Jones A.E.; Wright G.W.; Davidson-Garcia C.A.; Toledo A.A.; Mitchell-Leef D.; Wininger J.D.

Preimplantation genetic diagnosis (PGD) as both a diagnostic and therapeutic tool in assisted reproductive technology (ART)
pp. 184-184(1)
Authors: Werlin L.B.; DeCherney A.; Rodi I.; Hill D.; Marello E.; Munne S.

The effect of oocyte morphology on aneuploidy rates and blastocyst formation in patients with repeated implantation failures following IVF/ICSI
pp. 184-184(1)
Authors: Balaban B.; Ercelen N.; Isiklar A.; Alatas C.; Urman B.

Preimplantation genetic screening of human embryos by PCR using an alternative non commercial method
pp. 184-184(1)
Authors: Xoconostle B.; Ruiz R.; Bermudez A.; Cuneo S.; Yerena C.; Najar A.G.

Assessment of aneuploidy and developmental potential of human embryos by fluorescence in situ hybridisation and amino acid profiling
pp. 185-185(1)
Authors: Clyde J.M.; Houghton F.D.; Rutherford A.J.; Hogg J.E.; Leese H.J.; Picton H.M.

The origin of biochemical pregnancies: lessons learned from preimplantation genetic diagnosis (PGD)
pp. 185-185(1)
Authors: Troncoso C.; Bosch E.; Rubio C.; Simon C.; Remohi J.; Pellicer A.

Embryo morphology grading and preimplantation genetic diagnosis to improve the predictive accuracy of embryo transfer in couples with advanced age and/or repeated implantation failures
pp. 185-185(1)
Authors: Ercelen N.; Balaban B.; Mumcu A.; Tutar E.; Mercan R.; Urman B.

The incidence of polyploid fertilization in patients with and without polycystic ovaries: is it a possible cause of early abortions?
pp. 185-186(2)
Authors: Ellenbogen A.; Michaely M.; Peer S.; Ballas S.

Pregnancy following successful preimplantation genetic diagnosis for alagille syndrome
pp. 186-186(1)
Authors: Xu K.; Spandorfer S.; Yuan H.; Veeck L.; Rosenwaks Z.

The number of available embryos for biopsy is predictive for the outcome of PGD cycles
pp. 186-186(1)
Authors: Abdelmassih S.; Nagy Z.P.; Abdelmassih V.; Abdelmassih R.; Munne S.

Comparison of assisted hatching on cellular fragment portion and empty perivitelline space in poor embryos
pp. 187-187(1)
Author: Cho K.